EP0000644A2 - Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions - Google Patents

Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions Download PDF

Info

Publication number
EP0000644A2
EP0000644A2 EP78300168A EP78300168A EP0000644A2 EP 0000644 A2 EP0000644 A2 EP 0000644A2 EP 78300168 A EP78300168 A EP 78300168A EP 78300168 A EP78300168 A EP 78300168A EP 0000644 A2 EP0000644 A2 EP 0000644A2
Authority
EP
European Patent Office
Prior art keywords
compound
radical
formula
same meanings
give
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP78300168A
Other languages
German (de)
French (fr)
Other versions
EP0000644A3 (en
Inventor
Takashi Kamiya
Youichi Shiokawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of EP0000644A2 publication Critical patent/EP0000644A2/en
Publication of EP0000644A3 publication Critical patent/EP0000644A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/14Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/50Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/16Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/164Unsaturated ethers containing six-membered aromatic rings
    • C07C43/168Unsaturated ethers containing six-membered aromatic rings containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/178Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1788Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C49/252Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
    • C07C57/48Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Definitions

  • the present invention is concerned with new lower cycloalkyl substituted-benzene derivatives. More particularly, the present invention is concerned with new lower cycloalkyl substituted-benzene derivatives and with the pharmaceutically-acceptable salts thereof, which have anti-inflammatory activity, with the processes for the preparation thereof, with pharmaceutical compositions comprising them and with methods for the treatment of inflammation by admini- atering the new derivatives to mammals.
  • the new lower cycloalkyl substituted-benzene derivatives of this invention are campounds of the general formula:-
  • the lower cycloalkyl radical for R 1 can contain 3 to 8 carbon atoms, preferably 5 to 7, examples of which may include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and the like.
  • the esterified carboxy radical for R may include substituted and unsubstituted lower alkoxy carbonyl, for example, methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, tert.-butoxycarbonyl, pentyloxycarbonyl, hexyloxycarbonyl, chloromethoxycarbonyl, bromoethoxycarbonyl, trifluoromethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, 2,2,2-tribromoethoxycarbonyl, 1-cyclopropylethoxycarbonyl, cyanomethoxycarhonyl, cyanoethoxycarbonyl, dimethylaminoethoxycarbonyl, dimethylaminopropoxycarbonyl, phenoxymethoxycarbonyl, phenoxyethoxycarbonyl, phenoxypropoxycarbonyl, pheny
  • the lower alkoxymethyl radicals for R 2 may include a methyl radical substituted by a lower alkoxy radical, for example, a mcthoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert.-butoxy, pentyloxy, hexyloxy, heptyloxy and the like.
  • the acyl moiety of the acyloxymethyl radical for R 2 may include substituted and unsubstituted lower alkanoyl, such as formyl, lower alkanoyl (e.g. acetyl, propionyl, butyryl, pentanoyl, hexanoyl, heptanoyl, trifluoroacetyl, chloroacetyl, etc.) or higher alkanoyl (e.g.
  • nonanoyl decanoyl, palmitoyl, etc.
  • lower alkoxycarbonyl such as methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, tert.-butoxycarbonyl, pentyloxycarbonyl, hexyloxycarbonyl and the like; substituted and unsubstituted aroyl such as benzoyl, toluoyl, xyloyl, naphthoyl, chlorobenzoyl, nitrobenzoyl, hydroxybenzoyl or the like; substituted and unsubstituted ar(lower)-alkanoyl such as phenylacetyl, phenylpropionyl, tolyl- acetyl, naphthylacetyl, chlorophenylacetyl, methoxyphenylacetyl
  • heterocyclic carbonyl such as furoyl, thenoyl, nicotinoyl and isonicotinoyl; lower alkanesulphonyl such as mesyl, ethanesulphonyl, propanesulphonyl, butanesulphonyl, pentanesulphonyl or the like; and arenesulphonyl such as benzenesulphonyl, toluenesulphonyl, naphthalenesulphonyl or the like.
  • the lower alkanoyl radical for R 3 may include the lower alkanoyl radical as illustrated above for the acyl moiety of the acyloxymethyl radical for R 2 , and preferably, formyl, acetyl and propionyl.
  • the lower alkyl moiety of the lower alkylamino and di(lower)alkylamino radicals which are substituents on the lower alkyl radical for R 3 may include normal. and branched chain alkyl such as methyl, ethyl, n-propyl, isopropyl, n-butyl, iaobutyl, sec.-butyl, tert.-butyl, pentyl, neopentyl, hexyl or the like.
  • acyl radical and the acyl moiety of the acylamino and acyloxy radicals which are substituents on the lower alkyl radical for R 3 may be the same as those illustrated hereinbefore as examples of the acyl moiety of the acyloxymethyl radical for R 2 .
  • the lower alkoxy radical substituted on the lower alkyl radical for R 3 may be the same as those illua- trated hereinbefore as examples of the lower alkoxy moiety of the lower alkoxymethyl radical for R 2 .
  • the heterocyclic ring containing the nitrogen atom which is formed by joining the lower alkyl moieties of the di(lower)alkylamino(lower)alkyl radical for R 3 may include N-containing 3 to 7 membered heterocyclic group, such as 1-aziridinyl, 1-azetidinyl, 1-pyrrolidinyl or piperidino.
  • the protective group for the carbonyl function of the acyl(lower)alkyl radical for R 3 preferably includes the acetal type of protective group, preferred examples of the protected carbonyl moiety including 1,3-dioxolan-2-ylidene, 4-methyl-1,3-dioxolan-2-ylidene, dimethoxy- methylene, diethoxymethylene and the like.
  • the halogen atom X can be fluorine, chlorine, bromine and iodine.
  • the lower alkylene radical Y includes branched and straight-chained radicals, such as methylene, ethylene, propylene, trimethylene, tetramethylene, pentamethylene, hexamethylene, 2,2-dimethyltrimethylene and the like.
  • Pharmaceutically acceptable salts of the compounds (I) include conventional non-toxic salts, such as inorganic base salts, for example, metal salts, such as alkali metal salts (e.g. sodiua salts, potassium salts, etc.), and alkaline earth metal salts (e.g. calcium salts, magnesium salts, etc.), and ammonium salts; organic base salts, for example, amine salts (e.g. trimethylamine, triethylamine, ethanolamine, diethanolamine, pyridine and dicyclohexylamine salts, etc.); inorganic acid salts (e.g. hydrochlorides, hydrobromides, sulphates, etc.) and organic acid salts (e.g. acetates, maleates, tartrates, lactates, methanesulphonates, etc.).
  • metal salts such as alkali metal salts (e.g. sodiua salts, potassium salts, etc.), and alkaline earth metal salt
  • the compounds (I) of the preaent invention can be prepared by the methods illustrated in the following:
  • a compound of the general formula (Ia):- wherein R 1 , R , X and Y have the same meanings as above, and is a lower alkanoyl radical can be prepared by reacting a compound of the general formula: wherein R 1 , R 2 , X and Y have the same meanings as above, with a lower alkanoic acid of the general formula: wherein has the same meaning as above, or with a reactive derivative thereof, preferably in the presence of a strong base.
  • methyl 4-cyclohexylphenyl acetate i.e. the compound (II) wherein R 1 is cyclohexyl, X is hydrogen atom, Y is bond and R 2 is methoxycarbonyl
  • R 1 is cyclohexyl
  • X is hydrogen atom
  • Y is bond
  • R 2 is methoxycarbonyl
  • Preferred examples of the reactive derivatives of the lower alkanoic acide (II) include acid halides, such as acid chlorides and acid bromides; acid azides; acid anhydrides, i.e. mixed and symmetrical acid anhydrides, and activated eatera, including those illustrated hereinbefore as the eaterified carboxy radical for R 2 .
  • Preferred examples of the strong bases to be used in this process include alkali metal hydrides, such as sodium or potassium hydride; alkali metal amides, such as sodium or potassium hydride; alkali metal amides, such as lithamide, aodamide and potassamide; alkali metal alkoxides, such as sodium methoxide, sodium ethoxide, sodium propoxide, potassium methoxide and potassium ethoxide; alkali metal phenoxides, such as lithium phenoxide, sodium phenoxide and potassium phenoxide; organic lithium compounds, such as phenyl lithium, butyl lithium, diethylaminolithium and N-methylanilinolithium and the like.
  • the reaction is usually carried out in a conventional organic solvent, such as diethyl ether, tetrahydrofuran, benzene, diethyl carbonate, N,N'- dimethylformamide, pyridine or the like.
  • a conventional organic solvent such as diethyl ether, tetrahydrofuran, benzene, diethyl carbonate, N,N'- dimethylformamide, pyridine or the like.
  • the lower alkanoic acid (III) or its reactive derivative when it is liquid, it can also be used as a solvent.
  • the reaction is usually carried out at ambient temperature to about the boiling point of the solvent, although the reaction temperature is not specially restricted.
  • the hydroxymethylene isomer (Ia) can, if desired, be converted into the corresponding compound (Ia') by heating in a solvent, such as benzene or toluene, or the alkanoyl compound (Ia') can also be converted into the hydroxymethylene isomer (Ia”) by treatment under basic conditions.
  • a solvent such as benzene or toluene
  • the alkanoyl compound (Ia') can also be converted into the hydroxymethylene isomer (Ia") by treatment under basic conditions.
  • the compound (Ia') and its isomer (Ia”) are to be understood to be so-called keto-enol tautomers, as illustrated by the following equilibrium, and are to be regarded as being substantially the same compound: wherein R 1 and X have the same meanings as above, is a carboxy or esterified carboxy group, is a hydrogen atom or a lower alkyl radical and Y' is a valency bond.
  • the reaction is preferably carried out in the presence of a strong base, such as is used in the above Preparation A.
  • a strong base such as is used in the above Preparation A.
  • the reaction is usually carried out in a solvent, such as dimethyl sulphoxide, dimethyl formamide or some other conventional solvent, at ambient tempsrature.
  • Compounds (Ib) can also be prepared by the following Preparation C.
  • the starting compounds (IV) can be prepared, for example, by Preparation A. It is to be noted that the starting compound (IV) includes the corresponding enol compound, as explained in Preparation A.
  • the reduction is carried out by conventional methods, for example, by using a reducing agent, such as an alkali metal borohydrate (e.g. lithium borohydrate, sodium borohydrate, potassium borohydrate or sodium cyanoborohydrate) or by catalytic reduction.
  • a reducing agent such as an alkali metal borohydrate (e.g. lithium borohydrate, sodium borohydrate, potassium borohydrate or sodium cyanoborohydrate) or by catalytic reduction.
  • the catalytic reduction is usually carried out in the presence of a conventional catalyst, such as Raney nickel, preferably at ambient temperature under atmospheric pressure and in a conventional solvent and the reduction using a reducing agent is usually carried out in a conventional solvent, preferably a polar solvent, such as water, tetrahydrofuran, methanol or ethanol, with cooling or at ambient temperature and optionally in the presence of a base, such as sodium hydroxide, sodium carbonate, potassium carbonate or sodium bicarbonate.
  • a reducing agent such as an alkali metal
  • esterified carboxy radical When a starting compound (IV) containing an esterified carboxy radical for R 2 is subjected to reduction, the esterified carboxy radical also is somtimes reduced simultaneously with the reduction of the lower alkanoyl group , depending upon the reaction conditions and/or the kind of reducing agent used to give a compound of the general formula:- wherein R 1 , , X and Y have the same meanings as above, it being understood that this is also within the scope of this process.
  • Compounds of the general formula:- 1 2 wherein R 1 , R 2 , X and Y have the same meanings as above and is a lower alkoxy(lower)alkyl radical can be prepared by reacting a compound of the general formula:- wherein R 1 , R 2 , X and Y have the same meanings as above and is a hydroxy(lower)alkyl or acyloxy-(lower)alkyl radical, with an alkylating agent.
  • the preferred alkylating agent can be a lower alkanol, lower alkyl halide (e.g.
  • lower alkyl chloride lower alkyl bromide or lower alkyl iodide
  • di(lower)alkyl sulphate lower alkyl alkane or arene sulphonate (e.g. lower alkyl mesylate, lower alkyl benzene sulphonate, lower alkyl tosylate, etc.) and the like, in which the examples of the lower alkyl moieties can be the same as those exemplified hereinbefore.
  • reaction conditions are preferably selected in dependence upon the nature of the starting compound (V) employed, as follows.
  • Alkylation of a compound of general formula (V), in which Y is a valency bond and R 2 is a carboxy or esterified carboxy group, is preferably carried out by reacting with a lower alkanol in the presence of a strong base, such as an alkali metal alkoxide, and alkylation of a compound (V), in which R 2 is a hydroxymethyl radical, is preferably carried out by reaction with a conventional alkylating agent other than a lower alkanol, such as an alkyl halide, dialkyl sulphate or the like, in the presence of a strong base, such as an alkali metal hydride, alkali metal alkoxide or the like.
  • a strong base such as an alkali metal alkoxide
  • the reaction is more preferably carried out by using an excess of the lower alkanol, without any other solvent, with cooling and, in the latter case, the reaction is usually carried out in a solvent, such as dimethyl formamide, tetrahydrofuran, dimethyl sulphoxide, monoglyme, hexamethylphosphoryltriamide or other conventional solvent, with cooling or at ambient temperature.
  • a solvent such as dimethyl formamide, tetrahydrofuran, dimethyl sulphoxide, monoglyme, hexamethylphosphoryltriamide or other conventional solvent, with cooling or at ambient temperature.
  • transesterification usually takes place as a side reaction so that the ester part of the esterified carboxy for R 2 is converted into the different ester part and/or hydrolysis of the esterified carboxy for R 2 sometimes also takes place as a side reaction so that the esterified carboxy for R 2 is converted into the corresponding free carboxylic acid or its salt.
  • the hydroxmethyl radical for R 2 of the starting comound (V) is sometimes alkylated to give a compound having a lower alkoxymethyl radical for R 2 .
  • compound of the general formula:- wherein R 1 , R 2 , X and Y have the same meanings as above and is a lower alkoxymethyl radical can be prepared by treating a compound of the general formula:- wherein R 1 , R 2 , X and Y have the same meanings as above, in the same manner as described above.
  • methyl 2-(4-cyclohexylphenyl)acrylate is known and can be prepared, for example, by the method described in Chemical Abstracts 66, 10765 d/1967 and the other compound (VI) can also be prepared according to this method.
  • the acylating agent can be a carboxylic or sulphonic acid having an acyl moiety as illustrated hereinbefore, or a salt or a reactive derivative thereof or a haloformic acid ester.
  • salts of carboxylic or sulphonic acids include salts with inorganic or organic bases, such as alkali metal salts (e.g. sodium salts, potassium salts, etc.), alkaline earth metal salts (e.g. calcium salts, magnesium aalts, etc.), organic base salts (e.-g. triethylamine salts, pyridine salts, etc.) and the like.
  • alkali metal salts e.g. sodium salts, potassium salts, etc.
  • alkaline earth metal salts e.g. calcium salts, magnesium aalts, etc.
  • organic base salts e.-g. triethylamine salts, pyridine salts, etc.
  • Examples of reactive derivatives of carboxylic sulphonic acids include acid halides, acid azides, acid anhydrides, activated amides and activated esters, such as those illustrated for the lower alkanoic acids (III) in the Preparation A.
  • the reaction ia usually carried out in a conventional solvent, such as methylene chloride, chloroform, benzene, diethyl ether, tetrahydrofuran, pyridine or the like, and preferably in the presence of an organic or inorganic base, such as an alkali metal bicarbonate (e.g. sodium or potassium bicarbonate, etc.), an alkali metal hydroxide (e.g. sodium or potassium hydroxide, etc.), or an organic base (e.g. triethylamine, dimethylbenzylamine, N-methylmorphorine, N-methylpiperidine, pyridine, etc.).
  • the reaction temperature is not particularly limited but the reaction is preferably carried out with cooling or at an ambient temperature.
  • the reaction is preferably carried out in the presence of a conventional condensation agent, such as a carbodiiaide compound (e.g. N,N'-dicyclohexylcarbodiimide, 8-cyclohexyl-N'- morpholinoethylearbodiimide, N-cyclohexyl-N'-(4-diethylaminocyclohexyl)-carbodiimide, N.N'-diethyl- carbodiimide, N,N'-diisopropylcarbodiimide, N-ethyl-N'-(3-dimethylaminopropyl)-carbodiimide, etc.), N,N'- carbonyl-bis-(2-methylimidazole), pentamethyleneketone-N-cyclohexylimine, diphenylketene-N-cyclohexylimine, an amide(N-bis-(2-methylimidazole), pentamethyleneketone
  • the lower alkyl moiety of the lower alkylamines and di(lower)alkylamines employed can be the same as those illustrated hereinbefore.
  • saturated heterocyclic imine compounds containing an imino group examples include aziridine, azetidine, pyrrolidine and piperidine.
  • reaction of a compound (VIII) with ammonia ot an amine is preferably carried out by using an excess amount thereof, for example two or more mole equivalents of ammonia or of the amine.
  • the reaction is also preferably carried out in the presence of a strong base, as illustrated in the case of Preparation A.
  • the reaction is usually carried out in a solvent, such as water, methanol, ethanol, tetrahydrofuran, dioxan, N,N-dimethylformamide or some other conventional solvent, with cooling or at ambient temperature.
  • Examples of the reducing agent to be employed for the reaction of the compound (IX) with ammonia or an amine include those exemplified in Preparation C.
  • the reaction of a compound (IX) with ammonia or an amine is usually carried out in a solvent,such as tetrahydrofuran, methanol, ethanol or n-propanol, with cooling or at ambient temperature.
  • a solvent such as tetrahydrofuran, methanol, ethanol or n-propanol
  • the reaction employing a compound (IX) can especially be used to prepare a compound having an aminomethyl, lower alkylaminomethyl or di(lower)alkylaminomethyl radical, in which the lower alkyl moieties of the di(lower)alkylamino group can be joined together to form a saturated heterocyclic radical containing a nitrogen atom, as in formula (If).
  • acylating agents to be employed in this process can be the same as those exemplified in Preparation E.
  • the reaction when a free carboxylic or sulphonic acid or a salt thereof is nsed as acylating agent, the reaction is preferably carried out in the presence of a conventional condensation agent as exemplified in Preparation E. Furthermore, when a reactive derivative of a carboxylic or sulphonic acid or a haloformic acid eater is used as acylating agent, the reaction is preferably carried out in the presence of an inorganic or organic base, such as sodium bicarbonate, sodium carbonate, sodium hydroxide, triethylamine, dimethylbenacylamine, N-methylmorphorine, N-methylpiperidine or pyridine.
  • the reaction conditions are substantially the same as thoae illustrated in Preparation E, i.e.
  • reaction is usually carried out in a conventional solvent, such as water, methylene chloride, chloroform, carbon tetrachloride, benzene or diethyl ether, while cooling.
  • a liquid condensation agent or a liquid base can also be used as solvent.
  • nitro(lowerr)alkanes examples include atraight- chained nitro(lower)alkanes, such as nitromethane, nitroethane, nitropropane, nitrobutane, nitropentane, nitrohexane or the like, and aryl-substituted nitro-(lower)alkane include phenyl-aubatituted straight- chaimed nitro(lower)alkane such as 1-nitro-2-phenylethane, phenyl-nitromethane and the like.
  • strong bases to be used in this process include inorganic bases, such as alkali metal hydrides (e.g. sodium hydride, potassium hydride and lithium hydride), alkali metal alkoxides (e.g. sodium alkoxides and potassium alkoxides and the like.
  • alkali metal hydrides e.g. sodium hydride, potassium hydride and lithium hydride
  • alkali metal alkoxides e.g. sodium alkoxides and potassium alkoxides and the like.
  • the reaction of the compound (XIII) or (XII) with the nitro(lower)alkane or aryl-substituted nitro-(lower)alkane is usually carried out in a solvent, such as methanol, ethanol, tetrahydrofuran or other conventional solvent, at ambient temperature.
  • a solvent such as methanol, ethanol, tetrahydrofuran or other conventional solvent, at ambient temperature.
  • the product thus ebtained can conveniently be treated with a mineral acid or an oxidising agent without isolation and/or purification.
  • Examples of the mineral acids to be used include hydrochloric acid and aulphuric acid.
  • oxidising agent to be used examples include conventional ones, such as permanganates (e.g. potassium permanganate), chromates (e.g. chromic acid) and the like.
  • permanganates e.g. potassium permanganate
  • chromates e.g. chromic acid
  • the treatment of the reaultant product with the mineral acid or oxidiaing agent can be carried out conventionally by introducing a mineral acid or an oxidiaing agent into the reaction mixture obtained above, with cooling.
  • the hydrolysis is usually carried out by treating a compound (XIII) with a base or an acid in water or an aqueous mixture of a hydrophilic organic solvent, such as methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran, acetone or the like.
  • a hydrophilic organic solvent such as methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran, acetone or the like.
  • the bases include inorganic and organic bases, such as alkali metal hydroxides (e.g. sodium hydroxide, potassium hydroxide, etc.), alkaline earth metal hydroxides (e.g. barium hydroxide, calcium hydroxide, magnesium hydroxide, etc.) and alkali metal alkoxides (e.g. sodium methoxide, sodium ethoxide, etc.).
  • alkali metal hydroxides e.g. sodium hydroxide, potassium hydroxide, etc.
  • alkaline earth metal hydroxides e.g. barium hydroxide, calcium hydroxide, magnesium hydroxide, etc.
  • alkali metal alkoxides e.g. sodium methoxide, sodium ethoxide, etc.
  • acids examples include inorganic acids, such as hydrochloric acid, hydrobromic acid and aulphuric acid, and organic acids, such as formic acid, trifluoroacetic acid, methanesulphonic acid and p-toluenesulphonic acid.
  • reaction conditions used depend upon the nature of starting material (XIII) and the nature of the reagent, i.e. acid or base, and the reaction is usually carried out with cooling, at ambient temperature or with warming or heating.
  • the hydrolysis is preferably carried out by using an acid, such as formic acid, methanesulphonic acid, p-toluenesulphonic acid or aulphuric acid, or a mixture thereof.
  • the compound (Ii) can also be prepared by reacting a compound of the general formula:- wherein R 1 , R 3 , X and Y have the same meanings as above and is an acyloxymethyl radical, with a diester of malonic acid in the presence of a base and then hydrolysing the resulatant compound of the ganeral formula:- wherein R 1 , R 3 , X and Y have the same meanings as above and COOR is an esterified carboxy group, and finally decarboxylating the resultant dicarboxylic acid.
  • the hydrolysis and decarboxylation reactions of this method can be carried out in a conventional manner, using the so-called malonic ester synthesis. According to this method, a compound having one more methylene radical than the starting material can be obtained.
  • the reduction of the compounds (XVI) is usually carried out by using a hydride type of reducing agent, such as lithium aluminium hydride, aluminium hydride, lithium trimethoxyaluminium hydride or diborane, in a solvent, such as diethyl ether, tetrahydrofuran, benzene or toluene.
  • a hydride type of reducing agent such as lithium aluminium hydride, aluminium hydride, lithium trimethoxyaluminium hydride or diborane
  • a solvent such as diethyl ether, tetrahydrofuran, benzene or toluene.
  • the redaction can also be carried out by uaing sodium borohydride in the presence of a Lewis acid, such as aluminium chloride.
  • the reaction is usually carried out with cooling or at a somewhat elevated temperature but the reaction temperature ia net particularly restricted.
  • Transformation of the carbonyl function from the protected carbonyl group ia usually carried out by subjecting the reduction product to hydrolysis or transacetalisation.
  • the hydrolysis is preferably carried out by treating the product in the presence of an inorganic acid, such as hydrochloric acid or sulphuric acid, or with an organic acid, such as formic acid, trifluoroacetic acid or p-toluena- sulphonic acid, in conventional manner
  • the transacetalisation reaction is usually carried out by treating the product with an excess amount of a ketone, such as acetone, in the presence of a catalytic amount of acid, as mentioned above, in a conventional manner.
  • the acylating agent to be used in this reaction includes those illustrated in Preparation E.
  • the acylation can be carried out in substantially the same manner as described above in Preparation E.
  • the product (Ik) in which R 3 is lower alkanoyl or acyl(lower)-alkyl
  • the compound (Ij) in which the carbonyl function of lower alkanoyl or acyl(lower)-alkyl for R 3 is protected, as the starting compound. This case is also included within the scope of this Preparation.
  • the oxidation of the compounds (Ij) is usually carried out by treating the compound Ij) with an oxidising agent, such as chromic acid or potassium permanganate, in a solvent, such aa acetic acid, acetone or water, or in a mixture thereof.
  • an oxidising agent such as chromic acid or potassium permanganate
  • the reaction is usually carried out with cooling but the reaction temperature is not restricted thereto.
  • the esterification is carried out by reacting the compound (I.l), a reactive carboxy derivative thereof or a salt thereof with an esterifying agent.
  • the preferred reactive derivatives of the carboxy group of the compounds (Il) include those illustrated for acylating agents in Preparation E, for example, acid halides, acid anhydrides, activated amides, activated esters and the like.
  • the esterifying agent can be a hydroxy compound and a reactive equivalent thereof.
  • the hydroxy compound include substituted and unsubstituted alcohols, examples of which are given in the case of the ester moiety described in the illustrations of the esterified carboxy radical for R 2 .
  • Preferred reactive equivalents of the hydroxy compounds include conventional ones, such as the corresponding halides, alkanesulphonates, arenesulphonates and salts of the hydroxy compound, diazoalkanes, diazoaralkanes and the like.
  • the reaction can be carried out in the presence or absence of a solvent, such as N,N-dimethylformamide, dimethylsulphoxide or any other solvent which does not adversely influence the reaction, with cooling or heating.
  • a solvent such as N,N-dimethylformamide, dimethylsulphoxide or any other solvent which does not adversely influence the reaction, with cooling or heating.
  • This reaction is preferably carried out in the presence of an inorganic or organic base, such as one of those exemplified in Preparation E.
  • a liquid hydroxy compound or base can also be used as the solvent in this reaction.
  • the reaction is preferably carried out in the presence of a conventional condensing agent, such as an inorganic or organic acid (e.g. hydrochloric acid, sulphuric acid, p-toluenesulphonic acid, etc.) or of one of those particularly illustrated hereinbefore in Preparation E.
  • a conventional condensing agent such as an inorganic or organic acid (e.g. hydrochloric acid, sulphuric acid, p-toluenesulphonic acid, etc.) or of one of those particularly illustrated hereinbefore in Preparation E.
  • the compound (I) may, if desired, be converted into a pharmaceutically-acceptable salt, such as an alkali metal salt (e.g. a sodium salt or potassium salt), an alkaline earth metal salt (e.g. a calcium salt or a magnesium salt), an organic amine salt (e.g. a triethylamine salt or a dicyclohexylamine salt), an inorganic acid salt (e.g. a hydrochloride, hydrobromide or sulphate), an organic acid salt (e.g. a tartrate or maleate) or an amino acid salt (e.g. an arginine salt, an aspartate or a glutamate), by conventional methods.
  • a pharmaceutically-acceptable salt such as an alkali metal salt (e.g. a sodium salt or potassium salt), an alkaline earth metal salt (e.g. a calcium salt or a magnesium salt), an organic amine salt (e.g. a triethylamine salt or a dicyclohe
  • the following pharmacological test data show that the compounds (I) of the present invention exhibit an anti-inflammatory activity and are useful as anti-inflammatory agents for treating inflammation in animals and mammals.
  • the compounds were regarded as being effective when the total of 3 points was below 1.5.
  • the valuation was determined as follows:
  • test results obtained are given in the following Table 1:
  • the stomach was removed from Sprague-Dawley rats, weighing about 180 g., after the animals were fasted overnight.
  • a strip of stomach fundus was suspended under initial tension of 0.6 g. in a 10 ml. organ bath containing Tyrode solution.
  • Arachidonic acid (1.0 x 10 -5 g/ml.) was employed as the spasmogen.
  • Several doses of the test compound were added to the individnal bath fluid 15 minutes before the addition of arachidonic acid. The value of contraction induced by arachidonic acid was measured and plotted as a dose-activity curve.
  • the ED 50 value of each test compound was obtained by interpolation from the dose-activity curve. The results obtained are given in the following Table 2.:-
  • the compounds(I) of the present invention are useful as anti-inflammatory agent.
  • the active compound is usually administered at a dosage of 10 to 500 mg., 1 to 4 times a day in the form of preparations, such as tablets, granules, powders, capsules, syrups, injections or suppositories.
  • the dosage can be increased or decreased, depending upon the age, weight or condition of the patient or upon the method of administration.
  • the compositions can be prepared in a conventional manner by using conventional solid or liquid carriers and additives.
  • the suspension was adjusted to pH 1 with 10% hydrochloric acid, while stirring under cooling with ice, the ether layer was separated off, washed with water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure.
  • the resultant crystals were recrystallized from a mixture of acetone and diethyl ether to give 1.752 g. p-cyclohexyltropic acid; m.p. 159 - 160.5°C.
  • Methyl 2-(p-cyclohexylphenyl)-2-formyl acetate were recovered from the trituration mother liquor by evaporating to dryness under reduced pressure.
  • Methyl 2-(p-cyclohexylploenyl)-3-hydroxyacrylate has the following characteristics:
  • the solut- .ion was treated with an ethereal solution of diazomethane and evaporated to dryness under reduced pressure.
  • the residue was chromatographed on a silica gel column, elution being carried out with chloroform after washing with a mixture of n-hexane and benzene.
  • the eluate was treated in a conventional manner to give 3.923 g. of oily methyl 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionate.
  • the aqueous solution was mixed with diethyl ether and adjusted to pH 1 with 10% hydrochloric acid, while cooling.
  • the ethereal layer was separated, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure to give colourless crystals. These crystals were dissolved in hot benzene and the solution was evaporated under reduced pressure. These operations were repeated three times and the resultant residue was finally treated with n-hexane.
  • the insoluble substance was filtered off to give 228 mg. of colourless crystals of methyl 2-(3-chloro-4-cyclohexylphenyl)-3-hydroxyacrylate.
  • the extract was combined with the organic layer obtained above, washed with a saturated aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then evaporated to dryness.
  • the oily residue was dissolved in a small amount of chloroform, chronatographcd on a silica gel column and then eluted with chloroform to give 3.59 g. of oily methyl m-chloro-p-cyclohexyl tropatc.
  • the extract was combined with the organic layer obtained above, washed successively with 10% hydrochloric acid, water, an aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure.
  • the oily residue was distilled under reduced pressure to give 2.904 g. methyl 3-acetoxy-2-(3-chloro-4-cyclohexylphenyl) propionate; b.p. 180 - 183°C./6 mm.Hg.
  • the extract was combined with the organic layer obtained above, washed successively with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure.
  • the oily residue was chromatographed on a silica gel column and eluted with benzene to give 8.78 g. of oily methyl 2-(3-chloro-4-cyclohexylplenyl) 3-methoxypropionate which was identical with the compound obtained in the Example 4-(2).
  • the tetrahydrofuran was distilled off under reduced pressure and the residue was extracted with ethyl acetate.
  • the extract was washed successively with an aqueous solution of sodium chloride, a saturated aqueous solution of sodium bicarbonate, water and an aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then concentrated under reduced pressure.
  • the precipitate in the concentrate was dissolved by heating and the solution was then left to stand at ambient temperature.
  • the precipitate was filtered off with suction, washed with cold ethyl acetate and then dried to give 5.34 g. 2-(3-chloro-4-cyclohexylphenyl)propane-1,3-diol.
  • An additional crop of 0.975 g. was recovered from the mother liquor. Total yied 6.31.5 g.; m.p. 123.5 - 124.5°C..
  • dimethyl formamide was added to the mixture over the course of 1.25 hours, with ice-cooling, and the mixture thereafter stirred at the same temperature for 2 hours, with cooling with ice-water for an hour and again at ambient temperature for 2 hours.
  • the reaction mixture was poured into water and the mixture extracted with ethyl acetate. The extract was washed thoroughly with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure.
  • the oily residue was chromatographed on a column of 150 g. silica gel, eluting with chloroform and then with a mixture of chloroform and acetone. From the chloroform eluate there were obtained 3.02 g.
  • the extract was combined with the ether layer obtained above, washed with water and then extracted with a saturated aqueous solution of sodium bicarbonate.
  • the extract was washed with diethyl ether, adjusted to pH 1 with 10t hydrochloric acid, with stirring and ice-cooling, and then extracted with diethyl ether.
  • the ether extract was washed with an aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and evaporated under reduced pressure.
  • the oily residue was dissolved in benzene and the solution was evaporated to remove the remaining acetic acid azeotropically.
  • the resultant residue was chromatographed on a silica gel column, eluting with chloroform, to give 1.24 g. of oily 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionic acid. This compound gradually crystallized when left to stand at ambient temperature.
  • the extract was washed with diethyl ether, adjusted to pH 1 with 10% hydrochloric acid, with ice-cooling, and then extracted again with diethyl ether.
  • the ether extract was dried over anhydrous magnesium sulphate and evaporated to dryness.
  • the residue was treated with n-hexane and left to stand in a refrigerator.
  • the precipitated 2-(4-cyclohexylphenyl)-acrylic acid (0.821 g.) was filtered off and the filtrate was evaporated under reduced pressure.
  • the oily residue was dissolved in 20 ml. n-propanol, treated with a solution of 720 mg. sodium hydroxide in a small amount of water and then evaporated under reduced pressure.
  • the oily residue was dissolved in a small amount of benzene, chromatographed on an alumina column and eluted successively with benzene, chloroform and then with a mixture of chloroform and acetone.
  • the fractions obtained with chloroform and with a mixture of chloroform and acetone were combined, concentrated under reduced pressure, chromatographcd on a silica gel column and eluted successively with benzene, a mixture of benzene and chloroform, chloroform and then with a mixture of chloroform and acetone.
  • the fractions eluted with chloroform and a mixture of chloroform and acetone were combined and evaporated under reduced pressure.
  • aqueous extract was washed with diethyl ether, neutralized with a saturated aqueous solution of sodium bicarbonate until it became turbid and extracted with diethyl ether.
  • the extract was washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure to give 6.7 g. methyl 2-(4-cyclohexylphenyl)-3-mcthylaminopropionate.
  • the reaction mixture was poured dropwise into a chilled mixture of 200 ml. of 10% hydrochloric acid and 250 ml. methanol, with stirring. After stirring with ice-cooling for an hour and then at ambient temperature overnight, methannl was distilled off under reduced pressure. The aqueous solution was extracted with ethyl acetate and the extract was washed with water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was dissolved in a small amount of benzene, chromatographed on a silica gel column, eluted with benzene and then with a gradient mixture of benzene and chloroform (10:1 - 1:10 v/v) to give 15.213 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-3-acetylpropionate.
  • Nicotinoyl chloride hydrochloride were added portionwise to a mixture of 4.739 g. 2-(3-chloro-4-cyclohexylphenyl)-4,4-ethylenedioxypentanol, 4.242 g. triethylamine and 50 ml. methylene chloride, with stirring and ice-cooling, and the mixture stirred at the same temperature for 4 hours.
  • the reaction mixture was evaporated under reduced pressure and ethyl acetate and water added to the resultant residue. After shaking, the organic layer was separated and the remaining aqueous layer was extracted with ethyl acetate.
  • the extract and the organic layer were combined, washed with a saturated aqueous solution of sodium bicarbonate and then with water, dried over anhydrous magnesium sulphate and evaporated under reduced pressure.
  • the oily residue (6.92 g.) was dissolved in 60 ml. acetone and treated with 10 ml. 10% hydrochloric acid for 1.5 hours, with stirring and ice-cooling, and the acetone then distilled off under reduced pressure.
  • To the residue was added a mixture of ethyl acetate and a saturated aqueous solution of sodium bicarbonate, with stirring and ice-cooling, and the organic layer was separated off.
  • the extract was combined with the ethyl acetate solution obtained above, washed 4 times with 30 ml. amounts of cold 10% hydrochloric acid, and once each with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure.
  • the oily residue was chromatographed on a silica gel column and eluted with a mixture of n-hexane and benzene (1:1 v/v) to give 2.6 g. oily l-decanoyloxy-2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropane.
  • Palmitoyl chloride were added dropwise to a solution of 2.5 g. 2-(3-chloro-4-cyclohcxylphenyl)-3-methoxypropanol in 13.5 ml. pyridine at 3 - 5°C. over the course of 5 minutes and the mixture stirred at the same temperature for 6 hours..
  • the reaction mixture was treated in the same manner as described in Example 29 to give 5.2 g. of an oily residue which was chromatographed on a silica gel column and eluted with a mixture of benzene and.n-hexane to give 3.5 g. oily 1-palmitoyloxy-2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropane.
  • the reaction mixture was shaken with a mixture of water and ethyl acetate and the organic layer was separated. The remaining aqueous layer was extracted with ethyl acetate and the extract was combined with the organic layer obtained above, washed successively with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. Excess diethyl malonate was then also distilled off under reduced pressure. The oily residue obtained was dissolved in a small amount of benzene, chromatographed on a silica gel column and then eluted with benzene to give 2.27 g. oily diethyl 3-(3-chloro-4-cyclohexylphenyl)-4-methoxybutane-1,1-dicarboxylate.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions.
Lower cycloalkyl substituted-benzene derivatives of the formula:-
Figure imga0001
  • wherein R' is lower cycloalkyl,
  • R2 is carboxy, esterified carboxy, hydroxymethyl, lower alkoxymethyl or acyloxymethyl,
  • R3 is lower alkanoyl or lower alkyl substituted with hydroxy, amino, lower alkylamino, di(lower)alkylamino, acylamino, lower alkoxy, acyl or acyloxy, in which the lower alkyl moieties of the di(lower)alkyl amino radical may be joined together to form a heterocyclic ring containing the nitrogen atom and the carbonyl function of the acyl radical, which is a substituent on the lower alkyl radical, may be protected,
  • X is hydrogen or halogen, and
  • Y is a valency bond or lower alkylene;
    and pharmaceutically acceptable salts thereof;
    pharmaceutical composition comprising the same; and methods for treatment of inflammation by administering the same to mammals.

Description

  • The present invention is concerned with new lower cycloalkyl substituted-benzene derivatives. More particularly, the present invention is concerned with new lower cycloalkyl substituted-benzene derivatives and with the pharmaceutically-acceptable salts thereof, which have anti-inflammatory activity, with the processes for the preparation thereof, with pharmaceutical compositions comprising them and with methods for the treatment of inflammation by admini- atering the new derivatives to mammals.
  • The new lower cycloalkyl substituted-benzene derivatives of this invention are campounds of the general formula:-
    Figure imgb0001
    • wherein R1 is a lower cycloalkyl radical,
    • R2 is a carboxy, esterified carboxy, hydroxymethyl, lower alkoxymethyl or acyloxymethyl radical,
    • R3 is a lower alkanoyl radical or a lower alkyl radical substituted with a hydroxy, amino, lower alkylamino, di(lower)alkylamino, acy.lamino, lower alkoxy, acyl or acyloxy radical, in which the lower alkyl moieties of the di(lower)alkyl amino radical may be joined together to form a heterocyclic ring containing the nitrogen atom and the carbonyl function of the acyl radical, which is a substituent on the lower alkyl radical, may be protected,
    • X is a hydrogen or halogen atom, and
    • . Y is a valency bond or a lower alkylene radical;

    and the pharmaceutically acceptable salts thereof.
  • In this specification, it is to be understood that the term "lower" used in connection with an alkyl, .alkenyl, alkoxy, alkylene and alkanoyl radical is intended to mean the radicals containing up to eight carbon atoms, unless otherwise indicated.
  • As to the radicals as defined in the above, the more detailed explanation will be made and preferred examples thereof will be illustrated in the following.
  • The lower cycloalkyl radical for R1 can contain 3 to 8 carbon atoms, preferably 5 to 7, examples of which may include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl and the like.
  • The esterified carboxy radical for R may include substituted and unsubstituted lower alkoxy carbonyl, for example, methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, tert.-butoxycarbonyl, pentyloxycarbonyl, hexyloxycarbonyl, chloromethoxycarbonyl, bromoethoxycarbonyl, trifluoromethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, 2,2,2-tribromoethoxycarbonyl, 1-cyclopropylethoxycarbonyl, cyanomethoxycarhonyl, cyanoethoxycarbonyl, dimethylaminoethoxycarbonyl, dimethylaminopropoxycarbonyl, phenoxymethoxycarbonyl, phenoxyethoxycarbonyl, phenoxypropoxycarbonyl, phenyl- thiomethoxycarbonyl, phenylthioethoxycarbonyl, phenyl- thiopropoxycarbonyl, benzeneaulphinylmethoxycarbonyl, benzenesulphinylethoxycarbonyl, benzoylmethoxycarbonyl, toluoylethoxycarbonyl, 3,4,5-trimethoxyphenylpropoxycarbonyl, pyridylmethoxycarbonyl, furfuryloxycarbonyl, thsnyloxycarbonyl, 1,4-dioxanylmethoxycarbonyl, pyrrolidinylethoxycarbonyl, 4-methylpiperidinylethoxy- carbonyl and the like; lower alkenyloxycarbonyl, for example, vinyloxycarbonyl, 1-propenyloxycarbonyl, allyloxycarbonyl, 3-butenyloxycarbonyl and the like; lower alkynyloxycarbonyl, for example, ethynyloxy- carbonyl, propargyloxycarbonyl, 3-butynyloxycarbonyl, 4-pentynyloxycarbonyl and the like; lower cycloalkoxycarbonyl, for exampls, cyclopentyloxycarbonyl, cyclohexyloxycarbonyl and cycloheptyloxycarbonyl; substituted and unaubatituted aryloxycarbonyl, for example, phenoxycarbonyl tolyloxycarbonyl, xylyloxy- carbonyl, naphthoxycarbonyl, 4-chlorophenoxycarbonyl, 3,5-dibromphenoxyccarbonyl, pentachlorophenoxycarbonyl, 4-methoxyphenoxycarbonyl and the like; substituted and unsubstituted ar(lower)alkoxycarbonyl, for example, benzyloxycarbonyl, phenethyloxycarbonyl, 3,4-dichlorobenzyloxycarbonyl, 4-nitrobenzyloxycarbonyl, 4-methoxybenzyloxycarbonyl, 3,4,5-trimethoxybenzyloxycarbonyl, 3,4,5-trimethoxyphenylpropoxycarbonyl, 4-hydroxy-3,5-di-(tert.-butyl)-benzyloxycarbonyl and the like; ar(lower)alkenyloxycarbonyl, for example, cinnamyloxy- carbonyl and the like; heterocyclic-oxycarbonyl, for example, pyridyloxycarbonyl, picolyloxycarbcnyl, tetrahydropyranyloxycarbonyl, tetrahydrofuryloxy- carbonyl, quinolyloxycarbonyl, pyrazolyloxycarbonyl and the like; tri-(lower)alkylsilyloxycarbonyl, for example, trimethylsilyloxycarbonyl, triethylsilyloxy- carbonyl and the lilke; N,N-disubstituted aminoxycarbonyl, for example, isopropylidcneaminooxycarbonyl, cyanobenzylideneaminooxycarbonyl, phthalimidooxy- carbonyl, succinimidooxycarbonyl, 1-benzotriazolyloxy- carbonyl and the like.
  • The lower alkoxymethyl radicals for R2 may include a methyl radical substituted by a lower alkoxy radical, for example, a mcthoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert.-butoxy, pentyloxy, hexyloxy, heptyloxy and the like.
  • The acyl moiety of the acyloxymethyl radical for R2 may include substituted and unsubstituted lower alkanoyl, such as formyl, lower alkanoyl (e.g. acetyl, propionyl, butyryl, pentanoyl, hexanoyl, heptanoyl, trifluoroacetyl, chloroacetyl, etc.) or higher alkanoyl (e.g. nonanoyl, decanoyl, palmitoyl, etc.); lower alkoxycarbonyl, such as methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, tert.-butoxycarbonyl, pentyloxycarbonyl, hexyloxycarbonyl and the like; substituted and unsubstituted aroyl such as benzoyl, toluoyl, xyloyl, naphthoyl, chlorobenzoyl, nitrobenzoyl, hydroxybenzoyl or the like; substituted and unsubstituted ar(lower)-alkanoyl such as phenylacetyl, phenylpropionyl, tolyl- acetyl, naphthylacetyl, chlorophenylacetyl, methoxyphenylacetyl, hydroxyplienylacetyl or the like; substituted and unsubstituted aryloxy(lower)alkanoyl such as phenoxyacetyl, nitrophcnoxyacetyl or the like;
  • heterocyclic carbonyl such as furoyl, thenoyl, nicotinoyl and isonicotinoyl; lower alkanesulphonyl such as mesyl, ethanesulphonyl, propanesulphonyl, butanesulphonyl, pentanesulphonyl or the like; and arenesulphonyl such as benzenesulphonyl, toluenesulphonyl, naphthalenesulphonyl or the like.
  • The lower alkanoyl radical for R3 may include the lower alkanoyl radical as illustrated above for the acyl moiety of the acyloxymethyl radical for R2, and preferably, formyl, acetyl and propionyl.
  • The lower alkyl moiety of the lower alkylamino and di(lower)alkylamino radicals which are substituents on the lower alkyl radical for R3 may include normal. and branched chain alkyl such as methyl, ethyl, n-propyl, isopropyl, n-butyl, iaobutyl, sec.-butyl, tert.-butyl, pentyl, neopentyl, hexyl or the like.
  • The acyl radical and the acyl moiety of the acylamino and acyloxy radicals which are substituents on the lower alkyl radical for R3 may be the same as those illustrated hereinbefore as examples of the acyl moiety of the acyloxymethyl radical for R2.
  • The lower alkoxy radical substituted on the lower alkyl radical for R3 may be the same as those illua- trated hereinbefore as examples of the lower alkoxy moiety of the lower alkoxymethyl radical for R2.
  • The heterocyclic ring containing the nitrogen atom which is formed by joining the lower alkyl moieties of the di(lower)alkylamino(lower)alkyl radical for R 3 may include N-containing 3 to 7 membered heterocyclic group, such as 1-aziridinyl, 1-azetidinyl, 1-pyrrolidinyl or piperidino.
  • The protective group for the carbonyl function of the acyl(lower)alkyl radical for R3 preferably includes the acetal type of protective group, preferred examples of the protected carbonyl moiety including 1,3-dioxolan-2-ylidene, 4-methyl-1,3-dioxolan-2-ylidene, dimethoxy- methylene, diethoxymethylene and the like.
  • The halogen atom X can be fluorine, chlorine, bromine and iodine.
  • The lower alkylene radical Y includes branched and straight-chained radicals, such as methylene, ethylene, propylene, trimethylene, tetramethylene, pentamethylene, hexamethylene, 2,2-dimethyltrimethylene and the like.
  • Pharmaceutically acceptable salts of the compounds (I) include conventional non-toxic salts, auch as inorganic base salts, for example, metal salts, such as alkali metal salts (e.g. sodiua salts, potassium salts, etc.), and alkaline earth metal salts (e.g. calcium salts, magnesium salts, etc.), and ammonium salts; organic base salts, for example, amine salts (e.g. trimethylamine, triethylamine, ethanolamine, diethanolamine, pyridine and dicyclohexylamine salts, etc.); inorganic acid salts (e.g. hydrochlorides, hydrobromides, sulphates, etc.) and organic acid salts (e.g. acetates, maleates, tartrates, lactates, methanesulphonates, etc.).
  • with regard to the definition of the compounds of general formula (I) aa defined and explained above, it is to be noted that the definition "a lower alkyl radical subatituted with a hydroxy, amino, lower alkylamino, di(lower)alkylamino, acylamino, lower alkoxy, acyl or acyloxy radical" for R3 can also be expressed by the wording "a hydroxy(lower)alkyl, amino(lower)alkyl, lower alkylamino(lower)alkyl, di(lower)alkylanino(lower)-alkyl, acylamino(lower)alkyl, lower alkoxy(lower)alkyl, acyl(lower)alkyl or acyloxy(lower)alkyl". It is also to be noted that, when R3 of the compounds (I) is an acyl radical, the compounds (I) include the tautaseric isomenrs thereof, aa will be apparent from the following description.
  • The compounds (I) of the preaent invention can be prepared by the methods illustrated in the following:
  • (1) Preparation A:
  • A compound of the general formula (Ia):-
    Figure imgb0002
    wherein R1, R , X and Y have the same meanings as above, and
    Figure imgb0003
    is a lower alkanoyl radical, can be prepared by reacting a compound of the general formula:
    Figure imgb0004
    wherein R1, R2, X and Y have the same meanings as above, with a lower alkanoic acid of the general formula:
    Figure imgb0005
    wherein
    Figure imgb0006
    has the same meaning as above, or with a reactive derivative thereof, preferably in the presence of a strong base.
  • Of the starting compounds (II), methyl 4-cyclohexylphenyl acetate (i.e. the compound (II) wherein R1 is cyclohexyl, X is hydrogen atom, Y is bond and R2 is methoxycarbonyl) is known and can be prepared, for example, by the method described in Chemical Abstracts 66, 10765b/1967 and the other starting compounds (II) can be prepared in substantially the same manner aa described therein.
  • Preferred examples of the reactive derivatives of the lower alkanoic acide (II) include acid halides, such as acid chlorides and acid bromides; acid azides; acid anhydrides, i.e. mixed and symmetrical acid anhydrides, and activated eatera, including those illustrated hereinbefore as the eaterified carboxy radical for R2.
  • Preferred examples of the strong bases to be used in this process include alkali metal hydrides, such as sodium or potassium hydride; alkali metal amides, such as sodium or potassium hydride; alkali metal amides, such as lithamide, aodamide and potassamide; alkali metal alkoxides, such as sodium methoxide, sodium ethoxide, sodium propoxide, potassium methoxide and potassium ethoxide; alkali metal phenoxides, such as lithium phenoxide, sodium phenoxide and potassium phenoxide; organic lithium compounds, such as phenyl lithium, butyl lithium, diethylaminolithium and N-methylanilinolithium and the like.
  • The reaction is usually carried out in a conventional organic solvent, such as diethyl ether, tetrahydrofuran, benzene, diethyl carbonate, N,N'- dimethylformamide, pyridine or the like.
  • When the lower alkanoic acid (III) or its reactive derivative is liquid, it can also be used as a solvent. The reaction is usually carried out at ambient temperature to about the boiling point of the solvent, although the reaction temperature is not specially restricted.
  • In this reaction, it is to be noted that, when a starting compound of general formula (II), in which Y is a valency bond and R2 is a carboxy or esterified carboxy group, is used for the reaction, a compound (Ia') containing an alkanoyl radical is sometimes isolated in a form of the corresponding tautomeric hydroxymethylene compound of the formula (Ia") or of a mixture thereof, depending upon the conditions used for isolation. Furthermore, the hydroxymethylene isomer (Ia") can, if desired, be converted into the corresponding compound (Ia') by heating in a solvent, such as benzene or toluene, or the alkanoyl compound (Ia') can also be converted into the hydroxymethylene isomer (Ia") by treatment under basic conditions. The compound (Ia') and its isomer (Ia") are to be understood to be so-called keto-enol tautomers, as illustrated by the following equilibrium, and are to be regarded as being substantially the same compound:
    Figure imgb0007
    wherein R1 and X have the same meanings as above,
    Figure imgb0008
    is a carboxy or esterified carboxy group,
    Figure imgb0009
    is a hydrogen atom or a lower alkyl radical and Y' is a valency bond.
  • (2) Preparation B:
  • Compounds of the general formula:-
    Figure imgb0010
    wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0011
    is hydroxymethyl, can be prepared by reacting a compound of general formula (II) with paraformaldehyde.
  • The reaction is preferably carried out in the presence of a strong base, such as is used in the above Preparation A. The reaction is usually carried out in a solvent, such as dimethyl sulphoxide, dimethyl formamide or some other conventional solvent, at ambient tempsrature. Compounds (Ib) can also be prepared by the following Preparation C.
  • (3) Preparation C:
  • Compounds of the general formula:-
    Figure imgb0012
    wherein R1, R2, X and Y have the same meanings as above, and R3 is a hydroxy(lower)alkyl radical, can be prepared by reducing a compound of the general formula:-
    Figure imgb0013
    wherein R , R , X and Y have the same meanings as above, and
    Figure imgb0014
    is a lower alkanoyl radical.
  • The starting compounds (IV) can be prepared, for example, by Preparation A. It is to be noted that the starting compound (IV) includes the corresponding enol compound, as explained in Preparation A.
  • The reduction is carried out by conventional methods, for example, by using a reducing agent, such as an alkali metal borohydrate (e.g. lithium borohydrate, sodium borohydrate, potassium borohydrate or sodium cyanoborohydrate) or by catalytic reduction. The catalytic reduction is usually carried out in the presence of a conventional catalyst, such as Raney nickel, preferably at ambient temperature under atmospheric pressure and in a conventional solvent and the reduction using a reducing agent is usually carried out in a conventional solvent, preferably a polar solvent, such as water, tetrahydrofuran, methanol or ethanol, with cooling or at ambient temperature and optionally in the presence of a base, such as sodium hydroxide, sodium carbonate, potassium carbonate or sodium bicarbonate.
  • When a starting compound (IV) containing an esterified carboxy radical for R2 is subjected to reduction, the esterified carboxy radical also is somtimes reduced simultaneously with the reduction of the lower alkanoyl group
    Figure imgb0015
    , depending upon the reaction conditions and/or the kind of reducing agent used to give a compound of the general formula:-
    Figure imgb0016
    wherein R1,
    Figure imgb0017
    , X and Y have the same meanings as above, it being understood that this is also within the scope of this process.
  • (4) Preparation D:
  • Compounds of the general formula:-
    Figure imgb0018
    1 2 wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0019
    is a lower alkoxy(lower)alkyl radical, can be prepared by reacting a compound of the general formula:-
    Figure imgb0020
    wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0021
    is a hydroxy(lower)alkyl or acyloxy-(lower)alkyl radical, with an alkylating agent. The preferred alkylating agent can be a lower alkanol, lower alkyl halide (e.g. lower alkyl chloride, lower alkyl bromide or lower alkyl iodide), di(lower)alkyl sulphate, lower alkyl alkane or arene sulphonate (e.g. lower alkyl mesylate, lower alkyl benzene sulphonate, lower alkyl tosylate, etc.) and the like, in which the examples of the lower alkyl moieties can be the same as those exemplified hereinbefore.
  • The reaction conditions are preferably selected in dependence upon the nature of the starting compound (V) employed, as follows.
  • Alkylation of a compound of general formula (V), in which Y is a valency bond and R2 is a carboxy or esterified carboxy group, is preferably carried out by reacting with a lower alkanol in the presence of a strong base, such as an alkali metal alkoxide, and alkylation of a compound (V), in which R2 is a hydroxymethyl radical, is preferably carried out by reaction with a conventional alkylating agent other than a lower alkanol, such as an alkyl halide, dialkyl sulphate or the like, in the presence of a strong base, such as an alkali metal hydride, alkali metal alkoxide or the like. In the former case, the reaction is more preferably carried out by using an excess of the lower alkanol, without any other solvent, with cooling and, in the latter case, the reaction is usually carried out in a solvent, such as dimethyl formamide, tetrahydrofuran, dimethyl sulphoxide, monoglyme, hexamethylphosphoryltriamide or other conventional solvent, with cooling or at ambient temperature. Furthermore, in this reaction, it is to be noted that when the alkyl moiety of the alcohol to be used as a reagent in the reaction is different from the ester part of the esterified carboxy radical for R2 of the starting compound (V) (depending upon the reaction conditions, e.g. nature of the alkylating agent and the base, the presence of water and/or the reaction temperature, etc.), in the former case, transesterification usually takes place as a side reaction so that the ester part of the esterified carboxy for R2 is converted into the different ester part and/or hydrolysis of the esterified carboxy for R2 sometimes also takes place as a side reaction so that the esterified carboxy for R2 is converted into the corresponding free carboxylic acid or its salt.
  • Furthermore, when the alkylating agsnt is used in exceas in the latter case, the hydroxmethyl radical for R2 of the starting comound (V) is sometimes alkylated to give a compound having a lower alkoxymethyl radical for R2.
  • Furthermore, compound of the general formula:-
    Figure imgb0022
    wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0023
    is a lower alkoxymethyl radical, can be prepared by treating a compound of the general formula:-
    Figure imgb0024
    wherein R1, R2, X and Y have the same meanings as above, in the same manner as described above.
  • Of the starting compounds (VI), methyl 2-(4-cyclohexylphenyl)acrylate is known and can be prepared, for example, by the method described in Chemical Abstracts 66, 10765 d/1967 and the other compound (VI) can also be prepared according to this method.
  • (5) Preparation E:
  • Compounds of the general formula:-
    Figure imgb0025
    wherein R 1, R 2, X and Y have the same meanings as above and
    Figure imgb0026
    is an acyloxy(lower)alkyl radical, can be prepared by reacting a compound of the general formula:-
    Figure imgb0027
    wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0028
    ia a hydroxy(lower)alkyl radical, with an acylating agent.
  • The acylating agent can be a carboxylic or sulphonic acid having an acyl moiety as illustrated hereinbefore, or a salt or a reactive derivative thereof or a haloformic acid ester.
  • Examples of salts of carboxylic or sulphonic acids include salts with inorganic or organic bases, such as alkali metal salts (e.g. sodium salts, potassium salts, etc.), alkaline earth metal salts (e.g. calcium salts, magnesium aalts, etc.), organic base salts (e.-g. triethylamine salts, pyridine salts, etc.) and the like.
  • Examples of reactive derivatives of carboxylic sulphonic acids include acid halides, acid azides, acid anhydrides, activated amides and activated esters, such as those illustrated for the lower alkanoic acids (III) in the Preparation A.
  • The reaction ia usually carried out in a conventional solvent, such as methylene chloride, chloroform, benzene, diethyl ether, tetrahydrofuran, pyridine or the like, and preferably in the presence of an organic or inorganic base, such as an alkali metal bicarbonate (e.g. sodium or potassium bicarbonate, etc.), an alkali metal hydroxide (e.g. sodium or potassium hydroxide, etc.), or an organic base (e.g. triethylamine, dimethylbenzylamine, N-methylmorphorine, N-methylpiperidine, pyridine, etc.). The reaction temperature is not particularly limited but the reaction is preferably carried out with cooling or at an ambient temperature. When the acylating agent is used in the form of a free acid or in salt form, the reaction is preferably carried out in the presence of a conventional condensation agent, such as a carbodiiaide compound (e.g. N,N'-dicyclohexylcarbodiimide, 8-cyclohexyl-N'- morpholinoethylearbodiimide, N-cyclohexyl-N'-(4-diethylaminocyclohexyl)-carbodiimide, N.N'-diethyl- carbodiimide, N,N'-diisopropylcarbodiimide, N-ethyl-N'-(3-dimethylaminopropyl)-carbodiimide, etc.), N,N'- carbonyl-bis-(2-methylimidazole), pentamethyleneketone-N-cyclohexylimine, diphenylketene-N-cyclohexylimine, an alkoxyacetylene, a 1-alkoxy-l-chloroethylene, a trialkyl phosphite, ethyl polyphosphate, isopropyl polyphosphate, phosphorus oxychloride, phosphorus trichloride, thionyl chloride, oxalyl chloride, triphenylphosphine, N-ethylbenzisoxazolium salt, N-ethyl-5-phenyl-isoxazolium-3'-sulphonate, 1-(p-chlorobenzenesulphonyloxy)-6-chloro-1H-benzotriazole, a Vilsmeier reagent (e.g. (chloromethylene)-dimethylammonium chloride, a compound formed by the reaction of dimethylformamide with phosphorus oxychloride, etc.) or the like.
  • In this reaction, it is to be noted that, when a starting compound (VII) having a hydroxymethyl radical for R2 is used for the reaction, the hydroxy function of the hydroxymethyl radical for R2 of the starting compound (VII) can also be acylated to give the corresponding diacyl compound (i.e. the compound (Ie), in which R2 is acyloxymethyl, depending upon the amount of acylating agent used. It is to be understood that this mode of reaction ia also included within the scope of Preparation E.
  • (6) Preparation F:
  • Compounds of the general formula:-
    Figure imgb0029
    wherein R 1, R2, X and Y have the same meanings aa above and
    Figure imgb0030
    is an amino(lower)alkyl, lower alkylamino(lower)alkyl or di(lower)alkylamino(lower)alkyl radical, in which the lower alkyl moieties of the di(lower)alkylamino group can also be joined together to form a ring containing the nitrogen atom, can be prepared by reacting a compound of the general formula:-
    Figure imgb0031
    wherein R1, R2, X and Y have the same meanings aa above and
    Figure imgb0032
    is an acyloxy(lower)alkyl radical, with ammonia or an amine compound selected from alkylamines, di(lower)alkylanines and aaturated heterocyclic imine compounds containing an imino group, or by reacting a compound of the general formula:-
    Figure imgb0033
    wherein R1, R2, X and Y have the same meanings aa above, with ammonia or an amine compound selected from lower alkylamines, di(lower)alkylamines and saturated heterocyclic imine compounds containing an imino group, in the presence of a reducing agent.
  • The lower alkyl moiety of the lower alkylamines and di(lower)alkylamines employed can be the same as those illustrated hereinbefore.
  • Examples of saturated heterocyclic imine compounds containing an imino group include aziridine, azetidine, pyrrolidine and piperidine.
  • The reaction of a compound (VIII) with ammonia ot an amine is preferably carried out by using an excess amount thereof, for example two or more mole equivalents of ammonia or of the amine.
  • The reaction is also preferably carried out in the presence of a strong base, as illustrated in the case of Preparation A. The reaction is usually carried out in a solvent, such as water, methanol, ethanol, tetrahydrofuran, dioxan, N,N-dimethylformamide or some other conventional solvent, with cooling or at ambient temperature.
  • Examples of the reducing agent to be employed for the reaction of the compound (IX) with ammonia or an amine include those exemplified in Preparation C.
  • The reaction of a compound (IX) with ammonia or an amine is usually carried out in a solvent,such as tetrahydrofuran, methanol, ethanol or n-propanol, with cooling or at ambient temperature. The reaction employing a compound (IX) can especially be used to prepare a compound having an aminomethyl, lower alkylaminomethyl or di(lower)alkylaminomethyl radical, in which the lower alkyl moieties of the di(lower)alkylamino group can be joined together to form a saturated heterocyclic radical containing a nitrogen atom, as
    Figure imgb0034
    in formula (If).
  • (7) Preparation G:
  • Compounds of the general formula:-
    Figure imgb0035
    wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0036
    ia an acylamino(lower)alkyl radical, can be pregared by reacting a compound of the general formula:-
    Figure imgb0037
    wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0038
    is an amino(lower)alkyl radical, with an acylating agent.
  • The acylating agents to be employed in this process can be the same as those exemplified in Preparation E.
  • when a free carboxylic or sulphonic acid or a salt thereof is nsed as acylating agent, the reaction is preferably carried out in the presence of a conventional condensation agent as exemplified in Preparation E. Furthermore, when a reactive derivative of a carboxylic or sulphonic acid or a haloformic acid eater is used as acylating agent, the reaction is preferably carried out in the presence of an inorganic or organic base, such as sodium bicarbonate, sodium carbonate, sodium hydroxide, triethylamine, dimethylbenacylamine, N-methylmorphorine, N-methylpiperidine or pyridine. The reaction conditions are substantially the same as thoae illustrated in Preparation E, i.e. the reaction is usually carried out in a conventional solvent, auch as water, methylene chloride, chloroform, carbon tetrachloride, benzene or diethyl ether, while cooling. A liquid condensation agent or a liquid base can also be used as solvent.
  • (8) Proparation H:
  • Compounds of the general formula:-
    Figure imgb0039
    wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0040
    is an acyl(lower)alkyl radical, can be prepared by reacting a compound of the general formula:-
    Figure imgb0041
    wherein R1, R2, X and Y have the same meanings as above and
    Figure imgb0042
    is a hydrosy(lower)alkyl or acyloxy(lower)alkyl radical, or a compound of the general formula:-
    Figure imgb0043
    wherein R1, R2, X and Y have the same meanings as above, with nitro(lower)alkane or aryl-substituted nitro-(lower)alkane in the presence of a strong base, followed by treating the resultant product with a mineral acid or an exidising agent.
  • Examples of nitro(lowerr)alkanes include atraight- chained nitro(lower)alkanes, such as nitromethane, nitroethane, nitropropane, nitrobutane, nitropentane, nitrohexane or the like, and aryl-substituted nitro-(lower)alkane include phenyl-aubatituted straight- chaimed nitro(lower)alkane such as 1-nitro-2-phenylethane, phenyl-nitromethane and the like.
  • Examples of strong bases to be used in this process include inorganic bases, such as alkali metal hydrides (e.g. sodium hydride, potassium hydride and lithium hydride), alkali metal alkoxides (e.g. sodium alkoxides and potassium alkoxides and the like.
  • The reaction of the compound (XIII) or (XII) with the nitro(lower)alkane or aryl-substituted nitro-(lower)alkane is usually carried out in a solvent, auch as methanol, ethanol, tetrahydrofuran or other conventional solvent, at ambient temperature. The product thus ebtained can conveniently be treated with a mineral acid or an oxidising agent without isolation and/or purification.
  • Examples of the mineral acids to be used include hydrochloric acid and aulphuric acid.
  • Examples of the oxidising agent to be used include conventional ones, such as permanganates (e.g. potassium permanganate), chromates (e.g. chromic acid) and the like.
  • The treatment of the reaultant product with the mineral acid or oxidiaing agent can be carried out conventionally by introducing a mineral acid or an oxidiaing agent into the reaction mixture obtained above, with cooling.
  • When a compound of general formula (XII) ia used in this Preparation H, a compound (Ih) in which the radical
    Figure imgb0044
    is acylmethyl radical is obtained as the final product.
  • In the aforementioned Preparations D and F, the reaction of the hydroxymethyl and acyloxymetayl com- pounds (i.e. a compound (V) in which R3' d is hydroxymethyl or acyloxymethyl and a compound (VIII) in which
    Figure imgb0045
    is acyloxymethyl) sometimes proceeds via a compound of general formula (XII). Therefore, the compound (XII) can also be used as starting material in these Preparations.
  • (9) Preparation I:
  • Compounds of the general formula:-
    Figure imgb0046
    wherein R1, R3, X and Y have the same meanings aa above and
    Figure imgb0047
    is a carboxy radical, or a salt thereof, can be prepared by hydrolysing a compound of the general formula:-
    Figure imgb0048
    wherein R 1, R 3, X and Y have the same meanings aa above and
    Figure imgb0049
    is an eaterified carboxy radical.
  • The hydrolysis is usually carried out by treating a compound (XIII) with a base or an acid in water or an aqueous mixture of a hydrophilic organic solvent, such as methanol, ethanol, n-propanol, isopropanol, tetrahydrofuran, acetone or the like.
  • Examples of the bases include inorganic and organic bases, such as alkali metal hydroxides (e.g. sodium hydroxide, potassium hydroxide, etc.), alkaline earth metal hydroxides (e.g. barium hydroxide, calcium hydroxide, magnesium hydroxide, etc.) and alkali metal alkoxides (e.g. sodium methoxide, sodium ethoxide, etc.).
  • Examples of the acids include inorganic acids, such as hydrochloric acid, hydrobromic acid and aulphuric acid, and organic acids, such as formic acid, trifluoroacetic acid, methanesulphonic acid and p-toluenesulphonic acid.
  • The reaction conditions used depend upon the nature of starting material (XIII) and the nature of the reagent, i.e. acid or base, and the reaction is usually carried out with cooling, at ambient temperature or with warming or heating. When compounds having a lower alxoxy(lower)alkyl radical for R3 in general formula (XIII), in which the lower alkoxy moiety contains more than 2 carbon atoms, are employed as starting material, the hydrolysis is preferably carried out by using an acid, such as formic acid, methanesulphonic acid, p-toluenesulphonic acid or aulphuric acid, or a mixture thereof.
  • The compound (Ii) can also be prepared by reacting a compound of the general formula:-
    Figure imgb0050
    wherein R 1, R3, X and Y have the same meanings as above and
    Figure imgb0051
    is an acyloxymethyl radical, with a diester of malonic acid in the presence of a base and then hydrolysing the resulatant compound of the ganeral formula:-
    Figure imgb0052
    wherein R1, R3, X and Y have the same meanings as above and COOR is an esterified carboxy group, and finally decarboxylating the resultant dicarboxylic acid.
  • The hydrolysis and decarboxylation reactions of this method can be carried out in a conventional manner, using the so-called malonic ester synthesis. According to this method, a compound having one more methylene radical than the starting material can be obtained.
  • (10) Preparation J:
  • Compounds of the general formla:-
    Figure imgb0053
    wherein R1, R 3, X and Y have the same meanings as above and
    Figure imgb0054
    is a hydroxymethyl radical, can be prepared by reducing a compound of the general formula:-
    Figure imgb0055
    wherein R1, R , X and Y have the sams meanings as above and
    Figure imgb0056
    , is a carboxy or esterified carboxy radical.
  • The reduction of the compounds (XVI) is usually carried out by using a hydride type of reducing agent, such as lithium aluminium hydride, aluminium hydride, lithium trimethoxyaluminium hydride or diborane, in a solvent, such as diethyl ether, tetrahydrofuran, benzene or toluene. The redaction can also be carried out by uaing sodium borohydride in the presence of a Lewis acid, such as aluminium chloride.
  • The reaction is usually carried out with cooling or at a somewhat elevated temperature but the reaction temperature ia net particularly restricted.
  • When preparing compounds (Ij), wherein R3 is a lower alkanoyl or acyl(lower)alkyl radical, the corresponding carbonyl function of the acyl(lower)alkyl radical of the starting compound (XVI) is to be protected prior to carrying out this reduction and thereafter the protected carbonyl function is transformed into the carbonyl function. The protection of the carbonyl function can conveniently be carried out by reacting the compound (XVI) with a hydroxy compound, such aa ethylene glycol, in the presence of an acid in a conventional manner for well known acetalisations.
  • Transformation of the carbonyl function from the protected carbonyl group ia usually carried out by subjecting the reduction product to hydrolysis or transacetalisation. The hydrolysis is preferably carried out by treating the product in the presence of an inorganic acid, such as hydrochloric acid or sulphuric acid, or with an organic acid, auch as formic acid, trifluoroacetic acid or p-toluena- sulphonic acid, in conventional manner, and the transacetalisation reaction is usually carried out by treating the product with an excess amount of a ketone, such as acetone, in the presence of a catalytic amount of acid, as mentioned above, in a conventional manner.
  • When the above-mentioned carbonyl function of the starting compound (XVI) is not protected, the carbonyl function is sometimes reduced to give a diol compound (Ij) wherein R3 is a hydroxy(lower)alkyl radical. These cases are also included within the scope of this Preparation.
  • .(11) Preparation K :
  • Compounds of the general formula:-
    Figure imgb0057
    wherein R1, R 3, X and Y have the same meanings as above and
    Figure imgb0058
    is an acyloxymethyl radical, can be prepared by reacting the compound of the general formula:-
    Figure imgb0059
    wherein R1, R3, X and Y have the same meanings as above, with an acylating agent.
  • The acylating agent to be used in this reaction includes those illustrated in Preparation E.
  • The acylation can be carried out in substantially the same manner as described above in Preparation E. In this reaction, it ia to be noted that the product (Ik), in which R3 is lower alkanoyl or acyl(lower)-alkyl, is also isolated from the reaction mixing given by the reaction using the compound (Ij), in which the carbonyl function of lower alkanoyl or acyl(lower)-alkyl for R3 is protected, as the starting compound. This case is also included within the scope of this Preparation.
  • (12) Preparation L:
  • Compounds of the general formula:-
    Figure imgb0060
    wherein R1, R 3, X and Y have the same meanings as above, and the salts thereof can be prepared by oxidiaing a compound of the general formula:-
    Figure imgb0061
    wherein R1, R3, X and Y hava the same meanings as above.
  • The oxidation of the compounds (Ij) is usually carried out by treating the compound Ij) with an oxidising agent, such as chromic acid or potassium permanganate, in a solvent, such aa acetic acid, acetone or water, or in a mixture thereof.
  • The reaction is usually carried out with cooling but the reaction temperature is not restricted thereto.
  • (13) Preparation M:
  • compounds of the general formula:-
    Figure imgb0062
    wherein R1, R3, X and Y have the same meanings as above and
    Figure imgb0063
    is an esterified carboxy radical, can be prepared by esterifying a compound of the general formula:-
    Figure imgb0064
    wherein R1, R 3, X and Y have the same meanings as above.
  • The esterification is carried out by reacting the compound (I.ℓ), a reactive carboxy derivative thereof or a salt thereof with an esterifying agent.
  • The preferred reactive derivatives of the carboxy group of the compounds (Iℓ) include those illustrated for acylating agents in Preparation E, for example, acid halides, acid anhydrides, activated amides, activated esters and the like.
  • The esterifying agent can be a hydroxy compound and a reactive equivalent thereof. Examples of the hydroxy compound include substituted and unsubstituted alcohols, examples of which are given in the case of the ester moiety described in the illustrations of the esterified carboxy radical for R 2. Preferred reactive equivalents of the hydroxy compounds include conventional ones, such as the corresponding halides, alkanesulphonates, arenesulphonates and salts of the hydroxy compound, diazoalkanes, diazoaralkanes and the like.
  • The reaction can be carried out in the presence or absence of a solvent, such as N,N-dimethylformamide, dimethylsulphoxide or any other solvent which does not adversely influence the reaction, with cooling or heating. This reaction is preferably carried out in the presence of an inorganic or organic base, such as one of those exemplified in Preparation E. A liquid hydroxy compound or base can also be used as the solvent in this reaction.
  • If the free carboxylic acid form of the starting compound (Ii) or a salt and/or free hydroxy derivative thereof is employed in this preparation, the reaction is preferably carried out in the presence of a conventional condensing agent, such as an inorganic or organic acid (e.g. hydrochloric acid, sulphuric acid, p-toluenesulphonic acid, etc.) or of one of those particularly illustrated hereinbefore in Preparation E.
  • Although the reaction and/or post-treatment in the Preparations A to M may be sometimes accompanied by side reactions other than those mentioned hereinbefore, it is to be understood that the products obtained by such side reactions are also included within the scope of the compounds (I) of the present invention.
  • The compound (I) may, if desired, be converted into a pharmaceutically-acceptable salt, such as an alkali metal salt (e.g. a sodium salt or potassium salt), an alkaline earth metal salt (e.g. a calcium salt or a magnesium salt), an organic amine salt (e.g. a triethylamine salt or a dicyclohexylamine salt), an inorganic acid salt (e.g. a hydrochloride, hydrobromide or sulphate), an organic acid salt (e.g. a tartrate or maleate) or an amino acid salt (e.g. an arginine salt, an aspartate or a glutamate), by conventional methods.
  • The following pharmacological test data show that the compounds (I) of the present invention exhibit an anti-inflammatory activity and are useful as anti-inflammatory agents for treating inflammation in animals and mammals.
  • Test method (1):
  • Ten male 5 week old Hartley rats, each weighing about 350 g., were used per group. The backs of each animal were depilated 24 hours before the test. An adhesive tape with 3 small holes of 9 mm. diameter was placed on the depilated skin and then the animal was exposed to ultra-violet radiation from an ultra-violet lamp (500 W, manufactured by Engelhard Hanovia Inc.) at a distance of 13 cm. for 80 seconds. Two hours later, the degree of erythema was estimated on the basis of the following scores:
    • 1.0 : eryhthema with clear border,
    • 0.5 : erythema with unclear border,
    • 0.0 : scarcely any erythema.
  • The compounds were regarded as being effective when the total of 3 points was below 1.5.
  • The valuation was determined as follows:
    Figure imgb0065
  • Each dosage of the test compound was administered orally in a suspension form in 20 ml. of 0.5% aqueous methyl cellosolve aqueous solution. Half of the test sample was administered one hour before the radiation and the remaining half of the test solution was administered just after radiation. The test results obtained are given in the following Table 1:
    Figure imgb0066
  • Test Method (2) :
  • The stomach was removed from Sprague-Dawley rats, weighing about 180 g., after the animals were fasted overnight. A strip of stomach fundus was suspended under initial tension of 0.6 g. in a 10 ml. organ bath containing Tyrode solution.
    Arachidonic acid (1.0 x 10-5 g/ml.) was employed as the spasmogen. Several doses of the test compound were added to the individnal bath fluid 15 minutes before the addition of arachidonic acid. The value of contraction induced by arachidonic acid was measured and plotted as a dose-activity curve. The ED50 value of each test compound was obtained by interpolation from the dose-activity curve. The results obtained are given in the following Table 2.:-
    Figure imgb0067
  • As can be seen from the above test results, the compounds(I) of the present invention are useful as anti-inflammatory agent.
  • The active compound is usually administered at a dosage of 10 to 500 mg., 1 to 4 times a day in the form of preparations, such as tablets, granules, powders, capsules, syrups, injections or suppositories. However, the dosage can be increased or decreased, depending upon the age, weight or condition of the patient or upon the method of administration. The compositions can be prepared in a conventional manner by using conventional solid or liquid carriers and additives.
  • The following Examples are give for the purpose of illustrating the present invention:-
  • Example 1
  • (1) A solution of 28.8 mg. sodium in 2.5 ml. methanol was added dropwise to a suspension of 11.6 g. methyl p-cyclohexylphenylacetate and 1.5 g. paraformaldehyde in 30 ml. dinethyl sulphoxide over the course of 10 minutes, whereafter the reaction mixture was stirred at ambient temperature for 5 minutes. 0.3 ml. Acetic acid were added dropwise to the reaction mixture, whereafter ethyl acetate and cold water were added thereto. The mixture was shaken and the organic layer was then separated, successively washed with water, with a saturated aqueous solution of sodium bicarbonate and again with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was dissolved in n-hexane and the solution left to stand overnight. The precipitated crystals were filtered off with suction and washed with n-hexane to give 6.72 g. of colourless crystals of methyl p-cyclohexyl tropate. A further 1.17 g. of the same product was recovered from the mother liquor by concentration and crystallization. Total yield 7.89 g.; m.p. 83.5 - 85.5°C.
    • I.R.
      Figure imgb0068
      : 3250, 1735 cm-1
    • N.M.R. δppmCDCl3: 1.10 to 2.10 (10H, m) 2.26 to 2.76 (211, broad s) 3.64 (3H, s) 3.69 to 4.23 (3H, m) 7.10 to 7.33 (4H, m)
  • (2) 990.6 mg. Tosyl chloride was added all at . once to a cold solution of 1.048 g. methyl p-cyclohexyl tropate in 4 ml. pyridine and the reaction mixture was first stirred for 30 minutes while cooling with ice and then overnight at ambient temperature. Ethyl acetate was added to the reaction mixture, which was then washed successively with water, 5% hydrochloric acid, water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was crystallized by drying in a desiccator to give 1.598 g. of crystals of methyl 2-(4-cyclohexylphenyl)-3-tosylcxypropionate.
    • I.R.
      Figure imgb0069
      : 1730, 1365, 1170 cm-1
    • N.M.R. δppmCDCl3 : 1.05 to 2.15 (10H, m) 2.41 (3H, s) 3.59 (311, s) 3.69 to 4.71 (311, m) 6.92 to 7.35 (411, m) 7.28 (2H, d, J=8Hz) 7.71 (2H, d, J=8Hz)
    Example 2
  • A solution of 3.275 g. methyl p-cyclohexyl tropate, obtained in the Example 1-(1), in 20 ml. tetrahydrofuran was added dropwise to a suspension of 3.944 g. barium hydroxide octahydrate in 40 ml. water, with stirring, over the course of 15 minutes, while cooling with ice. The reaction mixture was stirred, with ice-cooling, for 3 hours and at ambient temperature for a further 5 hours and then left to stand overnight at ambient temperature. The precipitate was filtered off with suction, washed with a mixture of tetrahydrofuran and water (1:1 v/v) and then suspended in diethyl ether and water. The suspension was adjusted to pH 1 with 10% hydrochloric acid, while stirring under cooling with ice, the ether layer was separated off, washed with water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The resultant crystals were recrystallized from a mixture of acetone and diethyl ether to give 1.752 g. p-cyclohexyltropic acid; m.p. 159 - 160.5°C.
  • Analysis:
    • calc. for C15H20O3 : C 72.55%; H 8.12%
    • found : 72.63%; 8.23%
    • I.R.
      Figure imgb0070
      : 3500, 1715 cm-1
    • N.M.R. δppmDMSO-d6 : 1.10 to 2.03 (10H, m) 2.40 (1H, broad s) 3.40 to 4.03 (3H, m) 7.20 (4H, m)
    Example 3
  • (1) A solution of 23.2 g. methyl p-cyclohexylphenyl acetate in 7.2 g. methyl formate was added dropwise to a suspension of 50% sodium hydride (5.76 g.) in 150 ml. diethyl ether over the course of 25 minutes at 25 - 30°C., while stirring, and the reaction mixture then stirred at ambient temperature for 3 hours. Ice-water was added to the reaction mixture and the aqueous layer was separated off and washed with diethyl ether, 7.89 g. of unreacted starting material being recovered from the washings. The aqueous layer was mixed with diethyl ether and adjusted to pH 1 with 10% hydrochloric acid, while stirring under cooling with ice. The ether layer was separated off, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The residue was triturated with n-hexane and the resultant precipitate was filtered off to give 5.959 g. methyl 2-(p-cyclohexylphenyl)-2-hydroxymethyleneacetate. The mother liquor was evaporated to dryness under reduced pressure to give crude methyl 2-(p-cyclohexylphenyl)-2-formyl acetate. This formyl compound was converted into the above-mentioned hydroxymethylene compound as follows:
  • A cold solution of the crude formyl compound in a mixture of 1N aqueous sodium hydroxide and diethyl ether was adjusted to pH 1 with 10% hydrochloric acid. The diethyl ether layer was separated off, washed with water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The residue was triturated with n-hexane to give 4.434 g. of crystalline methyl 2-(p-cyclohexylphenyl)-3-hydroxyacrylate which was identified with a specimen of the compound obtained as above. 6.42 g. Methyl 2-(p-cyclohexylphenyl)-2-formyl acetate were recovered from the trituration mother liquor by evaporating to dryness under reduced pressure. Methyl 2-(p-cyclohexylploenyl)-3-hydroxyacrylate has the following characteristics:
    • I.R.
      Figure imgb0071
      : 3150, 1650 (sh), 1620 cm-1
    • N.M.R. δppmCDCl3 : 1.17 to 2.07 (10H, m) 2.26 to 2.76 (1H, broad s) 3.73 (3H, s) 5.92 (1H, d, J=14Hz) 7.10 to 7.40 (4H, m) 7.71 (1H, d, J=14Hz)
    Methyl 2-(p-cyclohexylphenyl)-2-formyl acetate has the following characteristics:
    • I.R. v liquid film : 1700, 1660, 1600 cm-1
    • N.M.R. δppmCDCl3 : 1.17 to 2.06 (10H, m) 2.25 to 2.74 (1H, broad s) 3.76 (3H, s) 7.10 to 7.32 (4H, m) 7.23 (1H, d, J=13Hz) 12.04 (1H, d, J=13Hz)
  • (2) A solution of 6.032 g. methyl 2-(p-cyclohexylphenyl)-3-hydroxyacrylate in 70 ml. methanol was shaken with hydrogen at atmospheric pressure in the presence of 15 ml. Raney nickel at ambient temperature. After the calculated amount of hydrogen (1 mole equivalent) had been adsorbed, the Raney.nickel was filtered off and the filtrate was evaporated to dryness under reduced pressure to give 5.93 g. crystalline methyl p-cyclohexyl tropate; m.p. 80.5 - 82.5°C.
    • I.R.
      Figure imgb0072
      : 3250, 1730 cm-1
    • N.M.R. δppmCDCl3 : 1.05 to 2.02 (10H, m) 2.25 to 2.68 (2H, broad s) 3.59 (3H, s) 3.56 to 4.18 (3H, m) 7.02 to 7.26 (4H, m)
  • (3) 2.97 g. Acetic anhydride were added dropwise to a solution of 5.45 g. methyl p-cyclohexyl tropate in 6 ml. pyridine over the course of 45 minutes, with stirring and cooling with ice. The reaction mixture was stirred at the same temperature for 2 hours. Diethyl ether was added to the reaction mixture and the mixture was washed successively with ice-cold 10% hydrochloric acid, water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was dried in vacuo to give 6.1 g. of crystalline methyl 2-(p-cyclohexylphenyl)-3-acetoxypropionate (6.1.g.)
    • I.R. v liquid fild : 1735 cm-1 max
    • N.R.M. δppmCDCl3 : 1.10 to 2.05 (10H, m) 2.07 (3H, s) 2.20 to 2.66 (1H, m) 3.74 (3H, s) 3.58 to 4.76 (3H, m) 7.30 to 7.40 (4H, m)
    Example 4
  • (1) About 1/3 volume of a solution of 66.7 mg. sodium in 5.8 ml. methanol was added dropwise to a solution of 15.457 g. methyl 2-(3-chloro-4-cyclohexylphenyl)acetate and 1.74 g. paraformaldehyde in 30 ml. dimethyl sulphoxide over the course of 5 minutes. After stirring the reaction mixture for 5 minutes, 0.3 ml. acetic acid was added dropwise thereto and further ethyl acetate and water were added. After shaking, the ethyl acetate layer was separated off. The remaining aqueous layer was extracted with ethyl acetate and the extract was combined with the ethyl acetate layer, washed successively with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure to give 18.12 g. of oily methyl m-chloro-p-cyclohexyltropate. This compound was used for the following reaction without purification.
  • (2) A solution of 0.23 g. sodium in 10 ml. methanol was added dropwise to a solution of 8.895 g. methyl m-chloro-p-cyclohexyltropate, obtained as above, in 50 ml. methanol over the course of 20 minutes under reflux and with stirring, whereafter the reaction mixture was stirred for 2 hours under the same conditions. After distilling off the methanol under reduced pressure, diethyl ether and water were added to the residue. The mixture was adjusted to pH 1 with 10% hydrochloric acid and the ether layer was separated, washed with water and dried over anhydrous magnesium sulphate. The solut- .ion was treated with an ethereal solution of diazomethane and evaporated to dryness under reduced pressure. The residue was chromatographed on a silica gel column, elution being carried out with chloroform after washing with a mixture of n-hexane and benzene. The eluate was treated in a conventional manner to give 3.923 g. of oily methyl 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionate.
    • I.R. v liq. film 1735 cm-1 max.
    • N.M.R. δppmCDCl3 : 1.10 to 2.07 (10H, m) 2.69 to 3.05 (1H, m) 3.28 (3H, s) 3.43 to 4.03 (3H, m) 3.61 (3H, s) 7.10 to 7.36 (3H, m)
  • (3) 2.484 g. of the methyl 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionate thus obtained were added to 50 ml. methanol and 7 ml. 10% aqueous sodium hydroxide solution and the reaction mixture was stirred at 70 - 75°C. for 1 hour. Methanol was distilled off under reduced pressure and ethyl acetate and water were added to the residue. The mixture was adjusted to pH 1 with 10t hydrochloric acid, while stirring and cooling with ice, and the ethyl acetate layer was separated off, washed with an aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was added to a solution of 0.3 g. sodium hydroxide in 10 ml. methanol and the mixture was evaporated to dryness under reduced pressure. The residue was dissolved in warm ethanol and a small amount of acetone was added to the solution. The mixture was left to stand at ambient temperature and the resultant precipitate was filtered off with suction and dried to give 1.772 g. of crystalline sodium 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionatc; m.p. 249.5 - 251°C. (decomposed).
  • Analysis:
    • calc. for C16H20C3ClNa : C 60.28%; H 6.32%; C1 11.12% found : 59.02%; 6.28%; 10.38%
    • I.R.
      Figure imgb0073
      : 1600 cm-1
    • N.M.R. δppmD2O : 0.89 to 2.13 (10H, m) 2.64 to 3.10 (1H, m) 3.25 (3H, s) 3.36 to 4.17 (3H, m) 7.10 to 7.56 (3H, m)
    Example 5
  • (1) A solution of 7.595 g. methyl 2-(3-chloro-4-cyclohexylphenyl)acetate and 2.052 g. methyl formate in 5 ml. anhydrous diethyl ether was added dropwise to a suspension of 0.821 g. sodium hydride, which had been prepared by washing 50% sodium hydride (1.642 g.) with petroleum ether in 40 ml. anhydrous diethyl ether for 20 minutes at 25 - 30°C., with stirring, and the reaction mixture was stirred at the same temperature for 3 hours. The reaction mixture was then poured into ice-water and the aqueous layer was separated off and washed with diethyl ether. The aqueous solution was mixed with diethyl ether and adjusted to pH 1 with 10% hydrochloric acid, while cooling. The ethereal layer was separated, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure to give colourless crystals. These crystals were dissolved in hot benzene and the solution was evaporated under reduced pressure. These operations were repeated three times and the resultant residue was finally treated with n-hexane. The insoluble substance was filtered off to give 228 mg. of colourless crystals of methyl 2-(3-chloro-4-cyclohexylphenyl)-3-hydroxyacrylate.
    • I.R.
      Figure imgb0074
      : 3150, 1630 cm-1
    The n-hexanc filtrate was evaporated to dryness under reduced pressure to give 5.14 g. of oily methyl 2-formyl-2-(3-chloro-4-cyclohexylphenyl) acetate.
    • I.R.
      Figure imgb0075
      : 1720, 1660, 1600 cm-1
  • (2) 4.8 g. of the methyl 2-formyl-2-(3-chloro-4-cyclohexylphenyl) acetate obtained were added to a mixture of 5 ml. tetrahydrofuran and 10 ml. of a saturated aqueous solution of carbonic acid and the reaction mixture was stirred, with ice-cooling, for 10 minutes. 1.716 g. sodium borohydride were added all at once to the solution and the mixture was stirred, while cooling with ice, for 5 minutes. Diethyl ether was added to the reaction mixture, followed by treatment with 10% hydrochloric acid to decompose excess sodium borohydride. The organic layer was separated off and the remaining aqueous layer was extracted with diethyl ether. The extract was combined with the organic layer obtained above, washed with a saturated aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then evaporated to dryness. The oily residue was dissolved in a small amount of chloroform, chronatographcd on a silica gel column and then eluted with chloroform to give 3.59 g. of oily methyl m-chloro-p-cyclohexyl tropatc.
    • I.R.
      Figure imgb0076
      . film 3420, 1730 cm-1
    • N.M.R. δppmCDCl3 : 1.08 to 2.08 (10H, m) 2.52 (1H, t, J=6Hz) 2.80 to 3.14 (1H, m) 3.70 (3H, s) 3.68 to 4.28 (3H, m) 7.06 to 7.36 (3H, m)

    Final elution with a mixture of chloroform and acetone gave 0.637 g. of crystalline 2-(3-chloro-4-cyclohexylphenyl)propane-1,3-diol as a by-product, which was identical with the compound prepared in Example 7-(1).
  • (3) 1.76 g. Acetic anhydride was added dropwise to a solution of 3.41 g. methyl m-chloro-p-cyclohexyl tropate in 4 ml. pyridine over the course of 10 minutes, while stirring, and the reaction mixture was then stirred, with ice-cooling, for 2 hours. Diethyl ether was added to the reaction mixture, while cooling with ice and stirring, and the mixture then acidified with 10% hydrochloric acid. The organic layer was separated off and the remaining aqueous layer was extracted with diethyl ether. The extract was combined with the organic layer obtained above, washed successively with 10% hydrochloric acid, water, an aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was distilled under reduced pressure to give 2.904 g. methyl 3-acetoxy-2-(3-chloro-4-cyclohexylphenyl) propionate; b.p. 180 - 183°C./6 mm.Hg.
  • Analysis:
    • calc. for C18H23O4Cl: C 63.81%; H 6.84%, Cl 10.46% found : 63.93%; 6.91%; 10.59%
    • I.R.
      Figure imgb0077
      film : 1740 cm-1
    • N.M.R. δppmCCl4 : 1.10 to 2.17 (10H, m) 1.97 (3H, s) 2.89 (1H, broad s) 3.68 (3H, s) 3.73 to 4.63 (3H, m) 7.07 to 7.36 (3H, m)
    Example 6
  • (1) 9.535 g. Tosyl chloride were added portionwise to a solution of 18.11 g. methyl m-chloro-p-cyclohexyl tropate, prepared as in Examples 5-(1) and (2), in 50 ml. pyridine while stirring and cooling with ice, and the reaction mixture was then stirred at the same temperature for 1.5 hours. Ethyl acertate and ice-water were added to the reaction mixture and shaken. The organic layer was separated, washed.successively with cold 10% hydrochloric acid, water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure to give 22.78 g. of oily methyl 3-tosyloxy-2-(3-chloro-4-cyclohexylphenyl) propionate which was used for the following reaction without further purification.
  • (2) A solution of 3.335 g. sodium in 60 ml. methanol was added dropwise to a solution of 22.77 g. methyl 3-tosyloxy-2-(3-chloro-4-cyclohexylphenyl) propionate in 250 ml. anhydrous methanol over the course of 45 minutes, while stirring at ambient temperature. After stirring the reaction mixture at ambient temperature for 5 hours, 7 ml. acetic acid were added dropwise to the reaction mixture. The mixture was evaporated to dryness under reduced pressure and ethyl acetate and ice-water were added to the resultant residue and shaken. The organic layer was separated off and the remaining aqueous layer was extracted with ethyl acetate. The extract was combined with the organic layer obtained above, washed successively with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was chromatographed on a silica gel column and eluted with benzene to give 8.78 g. of oily methyl 2-(3-chloro-4-cyclohexylplenyl) 3-methoxypropionate which was identical with the compound obtained in the Example 4-(2).
  • Example 7
  • (1) 2.923 g. Sodium borohydride were added portionwise, over the course of 3 minutes, to a suspension of 7.952 g. methyl 2-formyl-2-(3-chloro-4-cyclohexylphenyl) acetate, prepared as in Example 5- (1), in a mixture of 9 ml. tetrahydrofuran and 16 ml. of a saturated aqueous solution of carbonic acid, and,the reaction mixture was stirred for 15 minutes, with ice-cooling. 8 ml. Tetrahydrofuran were added to the mixture, followed by stirring for 45 minutes, with ice-cooling. A further 8 ml. tetrahydrofuran were added tp the mixture, which was then stirred at ambient temperature for 3 hours and adjusted to pH 1 with 10% hydrochloric acid, with ice-cooling.
  • The tetrahydrofuran was distilled off under reduced pressure and the residue was extracted with ethyl acetate. The extract was washed successively with an aqueous solution of sodium chloride, a saturated aqueous solution of sodium bicarbonate, water and an aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then concentrated under reduced pressure. The precipitate in the concentrate was dissolved by heating and the solution was then left to stand at ambient temperature. The precipitate was filtered off with suction, washed with cold ethyl acetate and then dried to give 5.34 g. 2-(3-chloro-4-cyclohexylphenyl)propane-1,3-diol. An additional crop of 0.975 g. was recovered from the mother liquor. Total yied 6.31.5 g.; m.p. 123.5 - 124.5°C..
  • Analysis:
    • calc. for C15H21O2Cl : C 67.03%; H 7.88%; Cl 13.19% found : 67.03%; 7.92%; 13.17%
    • I.R.
      Figure imgb0078
      : 3320 cm
    • N.M.R. ppmDMSO-d6 : 1.10 to 2.10 (10H, m) 2.59 to 3.13 (2H, m) 3.69 (4H, t, J=5Hz) 4.63 (2H, t, J=5Hz) 7.30 (3H, broad s)
  • (2) A solution of 15.573 g. 2-(3-chloro-4-cyclohexylphenyl)propane-1,3-diol in 55 ml. dimethyl formamide was added dropwise to a suspension of 1.46 g. sodium hydride, which had been prepared from 50% sodium hydride (2.923 g.) by washing with petroleum ether, in 30 ml. dimethyl formamide, over the course of one. minute, with stirring and ice-cooling, and the reaction mixture then stirred at the same temperature for 30 minutes. A solution of 8.648 g. methyl iodide in 15 ml. dimethyl formamide was added to the mixture over the course of 1.25 hours, with ice-cooling, and the mixture thereafter stirred at the same temperature for 2 hours, with cooling with ice-water for an hour and again at ambient temperature for 2 hours. The reaction mixture was poured into water and the mixture extracted with ethyl acetate. The extract was washed thoroughly with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was chromatographed on a column of 150 g. silica gel, eluting with chloroform and then with a mixture of chloroform and acetone. From the chloroform eluate there were obtained 3.02 g. 1,3-dimethoxy-2-(3-chloro-4-cyclohexylphenyl)propane as a by-product. This compound was distilled under reduced pressure to give 1.87 g. of the pure substance; b.p. 14.4-148°C./ 3 mm.Hg,
  • Analysis:
    • calc. for C17H25O2Cl : C 68.79%; H 8.49%; Cl 11.94% found : 68.76%; 8.62%; 12.38%
    • I.R.
      Figure imgb0079
      . film 1110 cm-1
    • N.M.R. δppmCDCl3 : 1.12 to 2.00 (10H, m) 2.76 to 3.20 (2H, m) 3.26 (6H, s) 3.44 to 3.72 (4H, m) 7.01 to 7.22 (3H, m)

    Fartheromre, 9.994 g. 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropanol were obtained from the fractions eluted with a mixture of chloroform and acetone; b.p. 156 - 158°C/3mm.Hg. Analysis:
    • calc. for C16H23O2Cl : C 67.95%; H 8.20%; Cl 12.54% found : 68.08%; 8.42%; 12.69%
    • I.R.
      Figure imgb0080
      . film 3400 cm-1
    • N.M.R. δppmCDCl3 : 1.13 to 2.10 (10H, m) 2.40 (lH, t, J=6Hz) 2.76 to 3.36 (2H, m) 3.36 (3H, s) 3.53 to 4.07 (4H, m) 7.10 to 7.36 (3H, m)
  • (3) A solution of 4.52 g. 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropanol in 15 ml. acetic acid was added dropwise to a solution of 4 g. chromium oxide in a mixture of 30 ml. acetic acid and 5 ml. water, with stirring and cooling below 5°C, and the reaction mixture then stirred at the same temperature for 3 hours and subsequently left to stand at ambient temperature for one day. Water and diethyl ether were added to the reaction mixture. After shaking, the ether layer was separated and the remaining aqueous layer was extracted with diethyl ether. The extract was combined with the ether layer obtained above, washed with water and then extracted with a saturated aqueous solution of sodium bicarbonate. The extract was washed with diethyl ether, adjusted to pH 1 with 10t hydrochloric acid, with stirring and ice-cooling, and then extracted with diethyl ether. The ether extract was washed with an aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and evaporated under reduced pressure. The oily residue was dissolved in benzene and the solution was evaporated to remove the remaining acetic acid azeotropically. The resultant residue was chromatographed on a silica gel column, eluting with chloroform, to give 1.24 g. of oily 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionic acid. This compound gradually crystallized when left to stand at ambient temperature.
  • Analysis:
    • calc. for C16H21O3Cl : C 64.75%; H 7.13%; Cl 11.95% found : 64.47%; 7.30%; 11.69%
    • I.R.
      Figure imgb0081
      : 1705 cm-1
    • N.M.R. δppmCDCl3 : 1.10 to 2.17 (10H, m) 2.76 to 3.23 (1H, broad s) 3.37 (3H, s) 3.53 to 4.03 (3H, m) 7.17 to 7.46 (3H, m) 10.73 (1H, broad s)
    Example 8
  • 2.938 g. Acetic anhydride were added dropwise, over the course of 15 minutes, to a solution of 3.222 g. 2-(3-chloro-4-cyclohexylphenyl)propane-1,3-diol in 6 ml. pyridine, with stirring and ice-cooling, and the reaction mixture then stirred at the same temperature for 2 hours and at ambient temperature for a further 2 hours and subsequently left to stand overnight at ambient temperature. Pyridine was distilled off under reduced pressure and the oily residue was dissolved in ethyl acetate. The solution was washed successively with water, 10% hydrochloric acid, water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The residue was distilled under reduced pressure to give 3.685 g. 1,3-diacetoxy-2-(3-chloro-4-cyclohexylphenyl)propane ; b.p. 191 - 193°C./3 mm.Hg. This compound crystallized upon standing at ambient temperature for a few days.
  • Analysis:
    • calc. for C19H25O4Cl : C 64.67%; H 7.14%; C1 10.05% found : 64.48%; 7.10%; 10.12%
    • I.R.
      Figure imgb0082
      film 1730 cm-1
    • N.M.R. δppmCCl4 : 1.06 to 2.05 (10H, m) 2.00 (6H, s) 2.76 to 3.10 (2H, m) 4.23 (4H, d, J=6Hz). 7.03 to 7.30 (3H, m)
    Example 9
  • A solution of 16 g. methyl m-chloro-p-cyclohcxyl tropate in 194.8 ml. tetrahydrofuran was added dropwise to a solution of 17.15 g. barium hydroxide in 198.4 ml. water, with ice-cooling, and the reaction mixture stirred at the same temperature for 2 hours and then at ambient temperature for 16 hours. The precipitate was filtered off and washed with tetrahydrofuran. Water and diethyl ether were added to the solid and the mixture was adjusted to pH 1 with hydrochloric acid. The ether layer was separated off, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryncss under reduced pressure. The resultant crystalline residue was recrystallized from a mixture of benzene and ethyl acetate to give 11 g. m-chloro-p-cyclohexyl tropic acid; m.p. 164 - 166°C.
  • Analysis:
    • calc. for C15H19O3Cl : C 63.71%; H 6.77%; Cl 12.54% found : 63.91%; 6.91%; 12.27%
    • I.R.
      Figure imgb0083
      : 3400, 1695 cm-1.
    • N.M.R. δppmDMSO-d6 : 1.05 to 2.08 (10H, m) 2.72 to 3.10 (1H, m) 3.44 to 4.08 (3H, m) 4.60 to 5.40 (lH, broad s) 7.05 to 7.52 (3H, m)
    Example 10
  • 3.143 g. Tosyl chloride were added all at once to a solution of 4.238 g. 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropanol in 15 ml. pyridine with stirring and ice-cooling, and the reaction mixture was stirred at the same temperature for 3 hours and then at ambient temperature for one hour. Diethyl ether and water were added to the reaction mixture. After shaking, the ether layer was separated off, washed successively with 10% hydrochloric acid, an aqueous solution of sodium chloride, a saturated aqueous solution of sodium bicarbonate and an aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure to give 6.0 g. oily 1-methoxy-2-(3-chloro-4-cyclohexylphenyl)-3-tosyloxy- propane.
    • I. R.
      Figure imgb0084
      film : 1360, 1170 cm
    • N.M.R. δppmCDCl3 : 1.10 to 2.10 (10H, m) 2.43 (3H, s) 2.76 to 3.14 (2H, m) 3.25 (311, s) 3.55 (2H, d, J=6Hz) 4.23 (211, d,d, J=2Hz, 7Hz) 6.89 to 7.79 (7H, m)
    Example 11
  • 492 mg. Sodium borohydride were added portionwise, over the course of 2 minutes, to a solution of 3.829 g. methyl 2-formyl-2-(3-chloro-4-cyclohexylphenyl)-acetate and 1.16 g. piperidine in 40 ml. tetrahydrofuran, with stirring and ice-cooling, and the reaction mixture was stirred for half an hour with ice-cooling and at ambient temperature for 4 hours and then left to stand overnight at ambient temperature. Excess sodium borohydride was decomposed with 10% hydrochloric acid and the mixture was evaporated under reduced pressure. Ethyl acetate and a saturated aqueous solution of sodium bicarbonate were added to the resultant residue. After shaking, the organic layer was separated off, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The residue was dissolved in a mixture of diethyl ether and water and the solution treated with 10% hydrochloric acid, with stirring. The resultant precipitate was filtered off with suction, washed with water and diethyl ether and then recrystallized from aqueous methanol containing a small amount of 10% hydrochloric acid to give 1.641 g. methyl 2-(3-chloro-4-cyclohexylphcnyl)-3-piperidinopropionate hydrochloride; m.p. 198.5 - 200°C. (dec.)
  • Analysis:
    • calc. for C21H30NO2Cl.HCl:
    • C 62.09%; H 7.80%; N 3.50%; C1 17.71% found: 63.02%; 7.87%; 3.67%; 17.48%
    • I.R.
      Figure imgb0085
      : 2600 to 2300, 1755 cm-1
    • N.M.R. δppmCDCl3 : 1.13 to 2.26 (16H, m) 2.30 to 4.03 (6H, m) 3.72 (3H, s) 4.76 (1H, d,d, J=4Hz, 9Hz) 7.13 to 7.46 (3H, m)
    Example 12
  • (1) A solution of 2.76 g. sodium in 80 ml. n-propanol was added dropwise over the course of half an hour to a suspension of 12.48 g. methyl 2-(4-cyclohexylphenyl)-3-tosyloxypropionate in 80 ml. n-propanol, while stirring at ambient temperature, and the reaction mixture was then stirred at the same temperature for one day. 7.2 ml. Acetic acid were added dropwise to the mixture and n-propanol was distilled off under reduced pressure from the reaction mixture. Ethyl acetate and water were added to the resultant residue. After shaking, the organic layer was separated off and the remaining aqueous layer was extracted with ethyl acetate. The extract and the organic layer obtained above were combined, washed successively with water, an aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated. The oily residue was dissolved in a small amount of benzene, chromatographed on a silica gel column and eluted with benzene to give 5.777 g. of oily propyl 2-(4-cyclohexylphenyl)-3-propoxypropionate.
    • I.R.
      Figure imgb0086
      film : 1730 cm-1
    • N.M.R. δppm CDCl3 : 0.84 (6H, t, J=8Hz) .1.06 to 2.12 (14H, m) 2.28 to 2.68 (lH, m) 3.39 (2H, t, J=8Hz) 3.52 to 4.24 (5H, m) 7.04 to 7.36 (4H, m)
  • (2) A mixture of 14.044 g. propyl 2-(4--cyclohexylphenyl)-3-propoxypropionate, 4.061 g. methanesulphonic acid, 39 ml. 98% formic acid and 4 ml. water was heated under reflux for 2.5 hours while stirring. Formic acid was distilled off from the reaction mixture under reduced pressure and cthyl acetate and cold water added to the resultant residue. After shaking, the ethyl acetate layer was separated off, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The residue was dissolved in 30 ml. n-propanol and the solution was treated with a solution of 1.6 g. sodium hydroxide in 8 ml. water, with stirring and ice-cooling, and then evaporated under reduced pressure. The residue was triturated with acetone and the resultant precipitate was filtered off, washed with acetone and then recrystallized from a mixture of n-propanol and acetone to give 10.9 g. sodium 2-(4-cyclohexylphenyl)-3-propoxypropionate; m.p. 223 - 224.5°C. This compound was identical to the specimen prepared in the following Example 13.
  • Example 13
  • 16.64 g. Methyl 2-(4-cyclohexylphenyl)-3-tosyloxy- propionate were added all at once to a solution of 3.68 g. sodium in 200 ml. n-propanol, with stirring and ice-cooling, and the reaction mixture was stirred at the same temperature for half an hour and then at ambient temperature for 20 hours. The mixture was treated with 7.2 ml. acetic acid and evaporated to dryness under reduced pressure. Ice-water and diethyl ether were added to the residue. After shaking, the organic layer was separated off and the remaining aqueous layer was extracted with diethyl ether. The extract and the organic layer obtained above were combined and extracted with an aqueous solution of sodium bicarbonate. The extract was washed with diethyl ether, adjusted to pH 1 with 10% hydrochloric acid, with ice-cooling, and then extracted again with diethyl ether. The ether extract was dried over anhydrous magnesium sulphate and evaporated to dryness. The residue was treated with n-hexane and left to stand in a refrigerator. The precipitated 2-(4-cyclohexylphenyl)-acrylic acid (0.821 g.) was filtered off and the filtrate was evaporated under reduced pressure. The oily residue was dissolved in 20 ml. n-propanol, treated with a solution of 720 mg. sodium hydroxide in a small amount of water and then evaporated under reduced pressure. The residue was crystallized by triturating with acetone and the resultant precipitate was filtered off with suction and recrystallized from a mixture of n-propanol and acetone to give 2.05 g. sodium 2-(4-cyclohexylphenyl)-3-propoxy-propionate; m.p. 223 - 224.5°C.
  • Analysis:
    • calc. for C18H25O3Na : C 69.21%; H 8.07%
    • found : 69.06%; 8.09%
    • I.R.
      Figure imgb0087
      : 1585 cm-1
    • N.M.R. δppmD2O : 0.69 (3H, t, J=6Hz) . 0.89 to 2.03 (12H, m) 2.03 to 2.59 (lH, broad s) 3.33 (2H, t, J=6Hz) 3.17 to 4.20 (3H, m) 7.07 (2H, d, J=8Hz) 7.31 (2H, d, J=8Hz)
    Example 14
  • (1) Gaseous ammonia was introduced vigorously into a solution of 12.48 g. methyl 2-(4-cyclohexylphenyl)-3-tosyloxypropionate in 400 ml. methanol for 30 minutes, with stirring and ice-cooling, and stirring was continued at ambient temperature for 7.5 hours, while slowly bubbling gaseous ammonia through the solution. The reaction vessel was sealed and left to stand overnight in a refrigerator and then the solvent was distilled off under reduced pressure. The residue was-treated with a mixture of diethyl ether and 5% hydrochloric acid and the resultant precipitate was filtered off, washed with a mixture of diethyl ether and water and then treated with a mixture of diethyl ether and an aqueous solution of sodium bicarbonate to give oily methyl 2-(4-cyclohexylphenyl)-3-amino- propionate. The aqueous layer was separated from the filtrate, washed with diethyl ether, rendered alkaline with sodium bicarbonate, while cooling with ice, and then extracted with diethyl ether. The extract was washed with water, dried over anhydrous magnesium sulphate and evaporated under reduced pressure to give the same oily product. Total yield 5.67 g.
    • I .R.
      Figure imgb0088
      film : 3350, 3300 cm-1
    • N.M.R. δppm CDCl3 : 1.08 to 2.04 (10H, m) 2.28 to 2.64 (1H, m) 2.78 to 3.42 (2H, m) 3.50 to 3.72 (1H, m) 3.64 (311, s) 7.16 (4H, s)
  • (2) A solution of 3.779 g. mesyl chloride in 15 ml. methylene chloride was added dropwise over the course of 40 minutes to a mixture of 8.613 g. methyl 2-(4-cyclohexylphenyl)-3-aminopropionate, 4 g. triethylamine, 3.326 g. sodium bicarbonate and 50 ml. methylene chloride, with stirring and ice-cooling, and the reaction mixture was stirred at the same tcm- perature for half an hour. The reaction mixture was evaporated under reduced pressure and a mixture of ethyl acetate and water was added to the residue. After shaking, the organic layer was separated and the remaining aqueous layer was extracted with ethyl acetate. The extract and the organic layer were combined, washed successively with water, 5% hydrochloric acid and water, dried over anhydrous magnesium sulphate and then concentrated under reduced pressure. The precipitate in the concentrate was dissolved again by heating and the solution was cooled to ambient temperature. The precipitate was filtered off with suction to give 2.802 g. crystalline methyl 2-(4-cyclohexylphenyl)-3-mesylamino- propionate. 2.058 g. of the same product were recovered by concentration and cooling. Total yield 4.860 g.; m.p. 138 - 140°C.
    • I. R.
      Figure imgb0089
      : 3430, 3150, 1300, 1140 cm
    • N.M.R. δppmDMSO-d6 : 1.08 to 1.96 (10H, m) 2.32 to 2.56 (1H, m) 2.80 (3H, s) 3.17 (lH, d,d, J=8Hz, 12Hz) 3.32 (lH, s) 3.42 to 3.92 (2H, m) 3.59 (3H, s) 7.19 (4H, s)
  • (3) A solution of 4.068 g. methyl 2-(4-cyclohexylphenyl)-3-mesylaminopropionate in 60 ml. tetrahydrofuran was added dropwise, over the course of an hour, to a suspension of 910.8 mg. lithium aluminium hydride in 40 ml. tetrahydrofuran, with stirring and ice-cooling, and the reaction mixture was stirred at the same temperature for half an hour. Ethyl acetate was added dropwise to the reaction mixture to decompose excess lithium aluminium hydride and then the reaction mixture was evaporated under reduced pressure. A mixture of ethyl acetate and 5% hydrochloric acid was added to the residue. The organic layer was separated off and the remaining aqueous layer was extracted with ethyl acetate. The extract and the organic layer were combined, washed with 5% hydrochloric acid and then with water, dried over anhydrous magensium sulphate and then evaporated to dryness under reduced pressure. The resultant crystals were recrystallized from benzene to give 3.104 g. 2-(4-cyclohexylphenyl)-3-mesylaminopropanol; m.p. 99 - 100.5°C.
  • Analysis:
    • calc. for C16H25NO3S :
    • C 61.70%; H 8.09%; N 4.50%; S 10.30% found: 61.66%; 8.15%; 4.45%; 10.14%
    • I.R.
      Figure imgb0090
      : 3500, 3200, 1300, 1140 cm-1
    • N.M R. δppmDMSO - d6 : 1.05 to 2.05 (10H, m) 2.25 to 3.03 (2H, m) 2.74 (3H, s) 3.18 (2H, m) 3.58 (2H, t, J=5Hz) 4.64 (1H, t, J=5Hz) 6.81 (1H, t, J=6Hz) 7.12 (4H, s)
    Example 15
  • (1) 24.96 g. Methyl 2-(4-cyclohexylphenyl)-3- tosyloxypropionate and 4.95 g. nitroethane were dissolved in 140 ml. hot methanol and the solution left to stand at ambient temperature. Over the course of 35 minutes, a solution of 2.898 g. sodium in 35 ml. methanol was added dropwise, with stirring at ambient temperature to the solution and the mixture stirred at the same temperature for 6 hours. Over the course of 20 minutes, a solution of 1.38 g. sodium in 50 ml. methanol was added dropwise with stirring and ice-cooling to the reaction mixture. The mixture was then added dropwise, over the course of an hour, to a mixture of 80 ml. 10% hydrochloric acid and 250 ml. mcthanol with stirring and ice-cooling, and the mixture was stirred at the same temperature for an hour and then at ambient temperature overnight. Methanol was distilled off under reduced pressure and the residue was extracted with ethyl acetate. The extract was washed successively with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The resultant crystals were recrystallized from methanol to give 5.742 g. methyl 2-(4-cyclohexylphenyl)-3-acetylpropionate; m.p. 86.5 - 90°C.
    • I.R.
      Figure imgb0091
      film : 1740 (sh), 1720 cm-1
    • N.M.R. δppmCDCl3 : 1.07 to 2.07 (10H, m) 2.15 (3H, s) 2.30 to 2.59 (1H, m) 2.66 (1H, d,d, J=4Hz, 18Hz) 3.25 (1H, d,d, J=10Hz, 18Hz) 3.63 (3H, s) 4.07 (1H, d,d, J=4Hz, 10Hz) 7.13 (4H, s)
  • (2) A mixture of 2.448 g. methyl 2-(4-cyclohexylphenyl)-3-acetylpropionate, 50 ml. methanol and 6.8 ml. 10% aqueous sodium hydroxide solution was heated under reflux, with stirring, for 10 minutes. Methanol was then distilled off under reduced pressure and the precipitated crystals were filtered off with suction and washed with water and then with ethyl acetate. These crystals were dissolved in a mixture of ethyl acetate and water and the solution adjusted to pH 1 with 10% hydrochloric acid, with ice-cooling. The ethyl acetate layer was separated, washed with water, dried over anhydrous magnesium sulnhate and then evaporated to dryness under reduced pressure. The resultant crystals were recrystallized from a mixture of benzene and n-hexane to give 1.972 g. 2-(4-cyclohexylphenyl)-3-acetylpropionic acid; m.p. 113.5 - 115°C.
  • Analysis:
    • calc. for C17H22O3 : C 74.42%, H 8.08%
    • found : 74.33%; 8:11%
    • I.R.
      Figure imgb0092
      : 1720, 1700 cm-1
    • N.M.R. δppmCDCl3 : 1.10 to 2.05 (10H, m) 2.13 (3H, s) 2.20 to 2.50 (lH, m) 2.65 (1H, d,d, J=5Hz, 18Hz) 3.33 (1H, d,d, J=10Hz, 18Hz) . 4.07 (1H, d,d, J=5Hz, 10Hz) 7.08 to 7.53 (4H, m) 9.46 to 10.00 (1H, broad s)
    Example 16
  • (1) A mixture of 3.744 g. methyl 2-(4-cyclohexyl phenyl)-3-acetylpropionate, 1 ml. ethylene glycol, 10 mg. p-toluenesulphonic acid monohydrate and 10 ml. benzene was heated under reflux, with stirring, for 5 hours, while removing water azetropically. After cooling, the reaction mixture was shaken with a mixture of benzene and an aqueous solution of sodium bicarbonate The organic layer was separated, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness to give 4.356 g. of oily methyl 2-(4-cyclohexylphenyl)-4,4-ethylenedioxyvaleratc.
    • I. R.
      Figure imgb0093
      film : 1735, 1140, 1040 cm-1
    • N.M.R. 6 ppmCDCl3 : 1.04 to 2.12 (11H, m) 1.31 (3H, s) 2.28 to 2.60 (1H, m) 2.74 (1H, d,d, J=10Hz, 14Hz) 3.61 (3H, s) 3.72 to 3.88 (1H, m) 3.91 (4H, s) 7.04 to 7.40 (4H, m)
  • (2) A solution of 4.648 g. methyl 2-(4-cyclohexylphenyl)-4,4-ethylenedioxyvalerate in 25 ml. diethyl ether was added dropwise over the course of 20 minutes to a suspension of 531.3 mg. lithium aluminum hydride in 50 ml. diethyl ether, with stirring and ice-cooling, and the mixture then stirred at the same temperature for half an hour. After decomposing excess lithium aluminium hydride by adding dropwise 3 ml. ethyl acetate, 10 ml. of a 15% aqueous solution of sodium hydroxide were added dropwise to the reaction mixture, with stirring and ice-cooling, whereafter a mixture of diethyl ether and a 15% aqueous solution of sodium hydroxide was added to the mixture. After shaking, the organic layer was separated and the remaining aqueous layer was extracted with diethyl ether. The extract and the organic layer obtained above were combined, washed with an aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was dried in a desiccator under reduced pressure to give 4.15 g. oily 2-(4-cyclohexylphenyl)-4,4-ethylenedioxypentanol.
    • I.R.
      Figure imgb0094
      film : 3450, 1140, 1040 cm-1
    • N.M.R. δppmCDCl3 : 1.10 to 2.01 (10H, m) 1.30 (3H, s) -2.09 (2H, d, J=6Hz) 2.26 to 2.69 (2H, broad s) 3.00 (1H, quintet, J=6Hz) 3.56 to 3.86 (2H,'m) 3.92 (4H, s) 7.10 (4H, s)
  • (3) A solution of 4,378 g. 2-(4-cyclohexylphenyl)-4,4-ethylenedioxypentanol in 44 ml. acetone was stirred with 2 ml. 10% hydrochloric acid at ambient temperature for half an hour. Acetone was distilled off under reduced pressure and the residue was shaken with a mixture of diethyl ether.and an aqueous solution of sodium chloride. The organic layer was separated off and the remaining aqueous layer was extracted with diethyl ether. The extract and the organic layer obtained above were combined, washed with an aqueous solution of sodium chloride solution, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was dissolved in a small amount of benzene, chromatographed on an alumina column and eluted successively with benzene, chloroform and then with a mixture of chloroform and acetone. The fractions obtained with chloroform and with a mixture of chloroform and acetone were combined, concentrated under reduced pressure, chromatographcd on a silica gel column and eluted successively with benzene, a mixture of benzene and chloroform, chloroform and then with a mixture of chloroform and acetone. The fractions eluted with chloroform and a mixture of chloroform and acetone were combined and evaporated under reduced pressure. The residue was dried under reduced pressure (2 mm.Hg) for 2 hours to give 2.553 g. of oily 2-(4-cyclohexylphenyl)-3-acetylpropanol which was left to stand for a few days to crystallize.
  • Analysis:
    • calc. for C17H24O2 : C 78.42%; H 9.29%
    • found : 78.74%; 9.48%
    • I.R,
      Figure imgb0095
      film 3400, 1710 cm-1
    • N.M.R. δppmCDCl3 : 1.06 to 2.02 (10H, m) 2.08 (3H, s) 2.20 to 2.64 (3H, m) 2.82 (1H, t, J=8Hz) 3.34 (1H, t, J=8Hz) 3.52 to 3.96 (2H, m) 7.05 to 7.32 (4H, m)
    Example 17
  • (1) A solution of 8.625 g. sodium in 100 ml. anhydrous methanol was added dropwise to a solution of 52 g. methyl 2-(4-cyclohexylphenyl)-3-tosyloxypropionate in 300 ml. anhydrous methanol over the course of 35 minutes at ambient temperature and then the mixture was stirred for 20 hours. The mixture was acidified with 22.7 g. acetic acid and evaporated under reduced pressure. The residue was shaken with a mixture of 150 ml. ethyl acetate and 150 ml. water and the ethyl acetate layer was separated off. The remaining aqueous layer was extracted twice with 50 m1. amounts of ethyl acetate and the extracts and the ethyl acetate layer obtained above were combined, washed successively with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure to give 35 g. methyl 2-(4-cyclohexylphenyl)-3-methoxypropionate.
    • I.R. v liq. film 1740 cm-1
    • N.M.R. δppmCDCl3 : 1.10 to 2.10 (10H, m) 2.21 to 2.68 (1H, broad s) 3.33 (3H, s) 3.45 to 4.12 (3H, m) 3.64 (3H, s) 7.12 to 7.36 (4H, m)
  • (2) To a solution of 8.85 g. methyl 2-(4-cyclohexylphenyl)-3-methoxypropionate in 180 ml. methanol were added 22 ml. of a 10% aqueous solution of sodium hydroxide and the mixture was stirred at ambient temperature for 1.5 hours. Methanol was distilled off under reduced pressure and water was added to the residue. Insoluble material was filtered off and dissolved in a mixture of ethyl acetate and water. The solution was adjusted to pH 1 with 10% hydrochloric acid, while cooling with ice-water. The ethyl acetate layer was separated off and the remaining aqueous layer was extracted with ethyl acetate. The extract and the ethyl acetate layer were combined, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness. The crystalline residue was recrystallized from n-hexane to give 4.8 g. 2-(4 cyclohexylphenyl)-3-methoxypropionic acid; m.p. 84 - 85°C.
  • Analysis:
    • calc. for C16H22O3 : C 73.25%; H 8.45%
    • found : 73.25%; 8.63%
    • I.R.
      Figure imgb0096
      : 1710 cm-1
    • N.M.R. δppmCDCl3 : 1.10 to 2.13 (1011, m) 2.26 to 2.79 (1H, m) 3.36 (3H, s) 3.50 to 4.20 (3H, m) 7.00 to 7.40 (411, m) 11.43 (1H, s)
    Exanple 18
  • (1) A solution of 11 g. methyl 2-(4-cyclohexylphenyl)-3-methoxypropianate in 40 ml. anhydrous diethyl ether was added dropwise over the course of 28 minutes to a suspension of 1.087 g. lithium aluminium hydride in 85 ml, anhydrous diethyl ether, with stirring and ice-cooling, and the mixture stirred at the same temperature for 40 minutes. To the mixture were added dropwise 25 ml. ethyl acetate and 10% hydrochloric acid, while cooling in an ice-water bath. The organic layer was separated off and the remaining aqueous layer was extracted with diethyl ether. The extract and the organic layer obtained above were combined, washed successively with a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was fractionated by vacuum distillation to give 7.87 g. 2-(4-cyclohexylphenyl)-3-methoxypropanol; b.p. 166 - 168°C./2 mm.Hg.
    • I.R. 1iq. film 3425, 1120 cm-1 max
    • N.M.R. δppmCDCl3 : 1.05 to 2.10 (10H, m) 2.20 to 2.68 (1H, m) 2.52 (1H, s) 2.91 to 3.3 (1H, m) 3.31 (3H, s) 3.5 to 4.05 (4H, m) 6.87 to 7.28 (4H, m)
  • (2) 408 mg. Acetic anhydride were added to a solution of 496.7 mg. 2-(4-cyclohexylphcnyl)-3-methoxypropanol in 2 ml. pyridine, while cooling in an ice-water bath, and the mixture was stirred at 5 - 8°C for 2 hours and at ambient temperature for an additional 5 hours and then left to stand in a refrigerator for 63 hours. The reaction mixture was diluted with ethyl acetate, washed successively with cold water, cold 10% hydrochloric acid, water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure to give 500 mg. of colourless, oily 1-acetoxy-2-(4-cyclohexylphenyl)-3-methoxyprohpane.
    • I.R.
      Figure imgb0097
      : 1740 cm-1
    • N.M.R. δppmCDCl3 : 1.10 to 2.05 (10H, m) 1.95 (3H, s) 2.28 to 2.62 (1H, m) 3.04 to 3.32 (1H, m) 3.28 (3H, s) 3.60 (2H, d, J=7Hz) 4.32 (2H, d, J=7Hz) 7.12 (4H, broad s)
    Example 19
  • 337.3 mg. Benzoyl chloride were added dropwise to a solution of 496.7 mg. 2-(4-cyclohexylphenyl)-3-methoxypropanol in 2 ml. pyridine, while cooling in an ice-water bath, and the reaction mixture then stirred at the same temperature for half an hour. Ethyl acetate and cold water were added to the reaction mixture. After shaking, the organic layer was separated off, washed successively with cold 10% hydrochloric acid, water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure to give 700 mg. of colourless, oily 1-benzoyloxy-2-(4-cyclohexylphenyl)-3-methoxypropane.
    • I.R.
      Figure imgb0098
      : 1725 cm-1
    • N.M.R. δppmCDCl3 : 1.03 to 2.10 (10H, m) 2.23 to 2.63 (1H, m) 3.17 to 3.56 (111, m) 3.31 (3H, s) 3.71 (2H, d, J=6Hz) 4.56 (2H, d, J=6Hz) 7.02 to 7.56 (7H, m) 7.86 to 8.13 (2H, m)
    Example 20
  • A solution of 5.46 g. 4-chlorophenoxyacctyl chloride in 10 ml. methylene chloride was added dropwise, over the course of 10 minutes, to a solution of 6 g. 2-(4-cyclohexylphenyl)-3-methoxypropanol in 5.74 g. pyridine, while cooling in an ice-water bath, and the mixture was stirred at the same temperature for half an hour. Methylene chloride was distilled off under reduced pressure and ethyl acetate and cold water added to the residue. After shaking the mixture, the ethyl acetate layer was separated off, washed successively with cold 10% hydrochloric acid, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure to give 11 g. of yellowish, oily 1-(4-chlorophenoxyacetoxy)-2-(4- cyclohexylphenyl)-3-methoxypropane.
    • I.R.
      Figure imgb0099
      . film 1770, 1740 (sh) cm-1
    • N.M.R. δppmCDCl3 : 1.08 to 2.12 (10H, m) 2.48 (1H, broad s) 3.10 to 3.36 (1H, m) 3.26 (3H, s) 3.53 (2H, d, J=6Hz) 4.36 to 4.68 (2H, m) 4.48 (211, s) 6.71 (2H, d, J=8Hz) 7.04 to 7.32 (6H, m)
    Example 21.
  • (1) 7.76 g. of a 30% ethanolic solution of methylamine were added dropwise to a solution of 10.4 g. methyl2-(4-cyclohexylphenyl)-3-tosyloxypropionate in 100 ml. mcthanol over the course of 5 minutes at ambient temperature and the mixture then stirred for 2.5 hours. Methanol was distilled off under reduced pressure. The residue was shaken with a mixture of diethyl ether, water and a saturated aqueous solution of sodium bicarbonate and the ether layer was separated off, washed with water and then extracted with 10% hydrochloric acid. The aqueous extract was washed with diethyl ether, neutralized with a saturated aqueous solution of sodium bicarbonate until it became turbid and extracted with diethyl ether. The extract was washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure to give 6.7 g. methyl 2-(4-cyclohexylphenyl)-3-mcthylaminopropionate.
    • I.R.
      Figure imgb0100
      . film : 3340, 1720 cm-1
    • N.M.R. δppmCDCl3 : 1.14 to 2.04 (10H, m) 1.48 (1H, s) 2.40 (3H, s) 2.28 to 2.64 (1H, m) 2.84 (1H, d,d, J=7Hz, 12Hz) 3.22 (1H, d,d, J=8Hz, 12Hz) 3.65 (3H, s) 3.79 (1H, d,d, J=7Hz, 8Hz) 7.28 (4H, broad s)
  • (2) A solution of 6 g. methyl 2-(4-cyclohexylphenyl)-3-methylaminopropionate in 10 ml. anhydrous diethyl ether was added dropwise to a suspension of 827 mg. lithium aluminium hydride in 40 ml. anhydrous diethyl ether over the course of 25 minutes, while cooling in an ice-water bath, and the mixture then stirred at the same temperature for 3 hours. To the reaction mixture were added dropwise 15 ml. ethyl acetate and then a 15% aqueous solution of sodium hydroxide, whereafter the mixture was extracted with diethyl ether. The extract was washed with a saturated aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The residue was dissolved in hot ethanolic hydrogen chloride, and diethyl ether was added to the cooled solution. The mixture was left to stand over-night and the precipitated crystals were filtered off and washed with diethyl ether to give 1.5 g. 2-(4-cyclohcxylphenyl)-3-mcthylaminopropanol hydrochloride. 500 mg. of the same hydrochloride were obtained from the mother liquor. These products were combined and recrystallized from isopropanol to give 1.8 g. of the pure hydrochloride; m.p. 178 - 180°C.
  • Analyses:
    • calc. for C16H25NO·HCl :
    • C 67.7%; H 9.23%; N 4.94%, C1 12.49% found : 67.50%; 9.30%; 4.93%; 12.74%
    • I.R.
      Figure imgb0101
      : 3300 to 2400 cm-1
    • N.M.R. δppmD2O : 1.08 to 2.20 (10H, m) 2.30 to 2.76 (1H, m) 2.83 (3H, s) 3.23 to 4.07 (5H, m) 7.36 (4H, t, J=10Hz)
    Example 22
  • A mixture of a solution of 3.5 g. methyl 2-(4-cyclohexylphenyl)-3-methylaminopropionate in 15 ml. isopropanol and a solution of 508.3 mg. sodium hydroxide in 1 ml. water was stirred at 70 - 80°C. for 2 hours and then left to stand at ambient temperature. The precipitated crystals were filtered off with suction, washed with a mixture of isopropanol and water (15:1 v/v) and then with isopropanol to give 2.2 g. sodium 2-(4-cyclohexylphenyl)-3-methylaminopropionate monohydrate; m.p. above 260°C.
  • Analysis:
    • calc. for C16H22NO2Na·H2O : C 63.47%; H 8.04%; N 4.63%
    • found : 63.20; 8.03%; 4.50%
    • I.R.
      Figure imgb0102
      : 1590, 3310 cm-1
    • N.M.R. δppmD2O : 0.89 to 2.00 (10H, m) 2.20 (3H, s) 2.30 to 2.76 (2H, m) 3.06 (1H, t, J=8Hz) 3.61 (1H, t, J=8Hz) 7.03 (2H, d, J=8Hz) 7.26 (2H, d, J=8Hz)
    Example 23
  • A solution of 1.242 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionate in 10 ml. anhydrous diethyl ether was added dropwise over the course of 15 minutes to a suspension of 152 mg. lithium aluminium hydride in anhydrous diethyl ether, with stirring and ice-cooling, and the reaction mixture then stirred at the same temperature for hxlf an hour. After decomposing excess lithium aluminium hydride by adding ethyl acetate, with stirring and ice-cooling. the mixture was shaken with a mixture of water 10% hydrochloric acid and diethyl ether and the organic layer was separated off. The remaining aqueous layer was filtered and the filtrate was extracted with diethyl ether. The extract and the organic layer were combined, washed with an aqueous solution of sodium chloride, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure to give 1.116 g. of oily 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropanol.
    • I.R.
      Figure imgb0103
      film : 3400 cm-1
    • N.M.R. δppmCDCl3 : 1.10 to 2.07 (10H, m) 2.57 (1H, broad s) 2.74 to 3.23 (2H, m) ; 3.28 (3H, s) 3.56 to 3.91 (4H, m) 7.07 to 7.30 (3H, m)
    Example 24
  • (1) A solution of 4.875 g. nitroethane in 15 ml. methanol was added dropwise over the course of 10 minutes to a solution of 2.243 g. sodium in 100 ml. methanol, while stirring at ambient temperature. To the mixture was added dropwise, over the course of an hour, a solution of 28.175 g. methyl 2-(3-chloro-4-cyclohexylphenyl)acrylate in 65 ml. methanol, while stirring at ambient temperature, and the mixture stirred at the same temperature for 3 hours. To the mixture was added dropwise an additional solution of 1.495 g. sodium in 40 ml. methanol over the course of 20 minutes, with stirring and ice-cooling. The reaction mixture was poured dropwise into a chilled mixture of 200 ml. of 10% hydrochloric acid and 250 ml. methanol, with stirring. After stirring with ice-cooling for an hour and then at ambient temperature overnight, methannl was distilled off under reduced pressure. The aqueous solution was extracted with ethyl acetate and the extract was washed with water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was dissolved in a small amount of benzene, chromatographed on a silica gel column, eluted with benzene and then with a gradient mixture of benzene and chloroform (10:1 - 1:10 v/v) to give 15.213 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-3-acetylpropionate.
    • I.R.
      Figure imgb0104
      film 1730, 1715 cm-1
    • N.M.R. δppmCDCl3 : 1.07 to 2.10 (10H, m) 2.17 (3H, s) 2.66 (1H, d,d, J=5Hz, 18Hz) 3.02 (1H, broad s) 3.23 (1H, d,d, J=8Hz, 18Hz) -3.68 (3H, s) 4.07. (1H, d,d, J=5Hz, 8Hz) 7.13 to 7.43 (3H, m)
  • (2) 4.193 g. Methyl 2-(3-chloro-4-cyclohexylphenyl)-3-acetylpropionate were added to a solution of 0.78 g. sodium hydroxide in 7 ml. water and 35 ml. methanol and the mixture heated under reflux for 30 minutes, while stirring. Methanol was distilled off under reduced pressure. The residual mixture was adjusted to pH 1 with 10% hydrochloric acid and extracted with ethyl acetate. The extract was washed with water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was triturated with a mixture of benzene and n-hexane and the precipitated crystals were filtered off with suction and washed with a mixture of benzene and n-hexane to give 2.763 g. 2-(3-chloro-4-cyclohexylphenyl)-3-acetylpropionic acid;
    • m.p. 117 - 118.5°C.f
    • Analysis:
    • calc. for C17H21O3Cl : C 66.12%; H 6.85%, Cl 11.48% found : 65.84%; 6.77%; 11.71% I.R.
      Figure imgb0105
      : 1720, 1710 (sh) cm-1
    • N.M.R. δppmCDCl3 :1.10 to 2.03 (10H, m) 2.13 (3H, s) 2.64 (1H, d,d, J=5Hz, 17Hz) 3.00 (lH, broad s) 3.31 (1H, d,d, J=10Hz, 17Hz) 4.05 (1H, d,d, J=5Hz, 10Hz) 7.13 to 7.38 (3H, m)
    Example 25
  • (1) A mixture of 7.256 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-3-acetylpropionate, 5 ml. ethylene glycol, 30 mg. p-toluenesulphonic acid monohydrate and 50 ml. benzene was heated under reflux for 6 hours, while stirring, the water being distilled off azeotropically. After cooling, the organic layer was separated off and the aqueous layer was extracted with benzene. The extract and the organic layer were combined, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness, under reduced pressure, to give .7.576 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-4,4-ethylenedioxyvalerate.
    • I. R.
      Figure imgb0106
      film : 1730, 1160, 1040 cm-1
    • N.M.R. δppmCDCl3 : 1.06 to 2.06 (11H, m) 1.28 (3H, s) 2.70 (1H, d,d, J=12Hz, 14Hz) 2.96 (lH, broad s) 3.62 (3H, s) 3.64 to 3.88 (1H, d,d, J=3Hz), 12 to 14Hz) 3.90 (4H, s) 7.12 to 7.40 (3H, m)
  • (2) A solution of 6.597 g. methyl 2-(3-chloro-4-cyclohcxylphenyl)-4,4-ethylenedioxyvalerate in 25 ml. anhydrous diethyl ether was added dropwise to a suspension of 683.1 mg. lithium aluminium hydride in 50 ml. anhydrous diethyl ether over the course of 80 minutes, with stirring and ice-cooling, whereafter the mixture was stirred at the same temperature for an hour. After decomposing excess lithium aluminium hydride by adding 4 ml. ethyl acetate, the mixture was shaken with a 15% aqueous solution of sodium hydroxide and the organic layer was separated off. The remaining aqueous layer was extracted with diethyl ether and the extract was combined with the organic layer obtained above, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure to give 5.745 g. of oily 2-(3-chloro-4-cyclohexylphenyl)-4,4-cthylcnedioxypcntanol.
    • I.R.
      Figure imgb0107
      film 3400, 1120,1040 cm-1
    • N.M.R. δppmCDCl3 : 1.07 to 2.10 (10H, m) 1.26 (3H, s) 2.05 (2H, d, J=6Hz) 2.58 (1H, broad s) 2.66 to 3.18 (1H, m) 2.94 (1H, quintet, J=6Hz) 3.68 (2H, d, J=6Hz) 3.91 (4H, s) 7.08 to 7.45 (3H, m)
  • (3) 102 mg. Acetic anhydride were added dropwise to a solution of 216.7 mg. 2-(3-chloro-4-cyclohexylphenyl)-4,4-ethylenedioxypentanol in 2 ml. pyridine, with stirring and ice-cooling, and the mixture was stirred at the same temperature for an hour and then at ambient temperature for 5 hours. The reaction mixture was diluted with ethyl acetate, washed successive-1y with chilled 5% hydrochloric acid, water, an aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure to give 197 mg. oily 1-acetoxy-2-(3-chloro-4-cyclohexylphenyl)-3-acetylpropane.
    • I.R.
      Figure imgb0108
      film : 1740, 1720 cm-1
    • N.M.R. δppmCDCl3 : 1.08 to 2.10 (10H, m) 1.96 (3H, s) 2.05 (3H, s) 2.78 (2H, d, J=6Hz) 3.00 (1H, broad s) 3.25 to 3.69 (111, m) 4.12 (1H, d,d, J=2Hz, 6Hz) 7.05 to 7.31 (3H, m)
    Example 26.
  • 140.5 mg. Benzoyl chloride were added to a solution of 225.4 mg. 2-(3-clloro-4-cyclohexylphcnyl)-4,4-ethylene dioxypentanol in 2 ml. pyridine, with stirring and ice-cooling, and the mixture was stirred at the same temperature for an hour. Ethyl acetate was added to the reaction mixture and the mixture washed successively with cold 5% hydrochloric acid, water, an aqueous solut- i.on of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure to give 232 mg. oily 1-benzoyloxy-2-(3-chloro-4-cyclohexylphenyl)-3-acctylpropane.
    • I. R.
      Figure imgb0109
      film : 1720 cm-1
    • N.M.R. ppmCDCl3 : 1.07 to 2.10 (10H, m) 2.10 (3H, s) 2.87 (2H, d, J=6Hz) 2.82 to 3.46 (2H, m) 4.41 (2H, d, J=7Hz) 7.13 to 7.69 (611, m) 7.86 to 8.17 (2H, m)
    Example 27
  • 2.741 g. Nicotinoyl chloride hydrochloride were added portionwise to a mixture of 4.739 g. 2-(3-chloro-4-cyclohexylphenyl)-4,4-ethylenedioxypentanol, 4.242 g. triethylamine and 50 ml. methylene chloride, with stirring and ice-cooling, and the mixture stirred at the same temperature for 4 hours. The reaction mixture was evaporated under reduced pressure and ethyl acetate and water added to the resultant residue. After shaking, the organic layer was separated and the remaining aqueous layer was extracted with ethyl acetate. The extract and the organic layer were combined, washed with a saturated aqueous solution of sodium bicarbonate and then with water, dried over anhydrous magnesium sulphate and evaporated under reduced pressure. The oily residue (6.92 g.) was dissolved in 60 ml. acetone and treated with 10 ml. 10% hydrochloric acid for 1.5 hours, with stirring and ice-cooling, and the acetone then distilled off under reduced pressure. To the residue was added a mixture of ethyl acetate and a saturated aqueous solution of sodium bicarbonate, with stirring and ice-cooling, and the organic layer was separated off. The remaining aqueous layer was extracted with ethyl acetate and the extract was combined with the organic layer, washed with a saturated aqueous solution of sodium bicarbonate and then with water, dried over anhydrous magnesium sulphate and evaporated under reduced pressure. The oily residue was chromatographed on a silica gel column and eluted with chloroform to give 4.658 g. oily 1-nicotinoyloxy-2-(3-chloro-4-cyclohexylpheyyl)-3-acetylpropane.
    • I. R.
      Figure imgb0110
      film : 1715 (broad) cm-1
    • N.M.R. δppmCDCl3 : 1.06 to 2.06 (lOH, m) 2.14 (3H, s) 2.78 to 3.16 (111, m) 2.94 (2H, d, J=7Hz) 3.72 (1H, quintet, J=7Hz) 4.50 (211, d, J=7Hz) 7.14 to 7.54 (4H, m) 8.18 to 8.36 (1H, m) 8.78 to 8.90 (1H, m) 9.20 (1H, d, J=2Hz)
    Example 28
  • (1) A solution of 6.318 g. 1-nitropcntane in 15 ml. methanol was added dropwise to a cold solution of 1.863 g. sodium in 100 ml. methanol, with stirring and ice-cooling. To the mixture was added dropwise a solution of 15.039 g. methyl 2-(3-chloro-4-cyclohexylphenyl)acrylate in 55 ml. methanol over the course of 30 minutes, with stirring and ice-cooling. After stirring for 5 hours at ambient temperature, a further solution of 1.242 g. sodium in 40 ml. methanol was added dropwise to the above mixture over the course of 30 minutes and the mixture then added dropwise to a cold mixture of 200 ml. 10% hydrochloric acid and 250 ml. methanol over the course of an hour, with stirring The resultant mixture was stirred at the same temperature for an hour and then overnight at ambient temperature. Methanol was distilled off under reduced pressure and the aqueous residue was extracted with ethyl acetate. The extract was washed successively with water, an aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was fractionated by vacuum distillation to give 8.802 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-3-pentanoyl- propionate; b.p. 185 - 198°C./2 mm.Hg. The 3.10 g. of distillate at 170 - 185°C./2 mm.Hg and the 5.18 g. of residue were combined, chromatographed on a silica gel column and eluted with benzene to give a further 2.21 g. of the same compound, the total yield being 11.012 g.
    • I.R.
      Figure imgb0111
      : 1730, 1710 cm-1
    • N.M.R. δppmCDCl3 : 0.88 (3H, t, J=7Hz) 1.10 to 2.12 (14H, m) 2.42 (2H, t, J=8Hz) 2.64 (1H, d,d, J=5, 17Hz) 2.98 (1H, broad s) 3.31 (1H, d,d, J=12, 17Hz) 3.65 (3H, s) 4.06 (1H, d,d, J=5, 12Hz) 7.03 to 7.09 (3H, m)
  • (2) 4.01 g. Methyl 2-(3-chloro-4-cyclohexylphenyl)-3-pentanoylpropionate were added to a solution of 0.66 g. sodium hydroxide in 6 ml. water and 30 ml. methanol and the mixture heated under reflux for 30 minutes, with stirring. Methanol was distilled off under reduced pressure and the residue was dissolved in water, washed with diethyl ether, acidified with 10% hydrochloric acid and then extracted with ethyl acetate. The remaining aqueous layer was washed with ethyl acetate and the washings were combined with the ethyl acetate extract obtained above, washed with water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was triturated with n-hexane and allowed to stand overnight in a refrigerator. The precipitate was filtered off, washed with n-hexane and then recrystallized from n-hexane to give 2.12 g. 2-(3-chloro-4-cyclohexylphenyl)-3-pentanoylpropionic acid; m.p. 86 - 87.5°C.
    • I. R.
      Figure imgb0112
      : 1710, 1705 (sh) cm-1
    • N.M.R. δppmCDCl3 : 0.86 (3H, t, J=7Hz) 1.06 to 2.09 (14H, m) 2.40 (2H, t, J=7Hz) 2.66 (1H, d,d, J=5, 17Hz) 2.97 (1H, broad s) 3.26 (1H, d,d, J=10, 17Hz) 4.06 (1H, d,d, J=5, 10Hz) 7.06 to 7.38 (3H, m) 10.25 (lH, broad s)
    Example 29
  • 2.48 g. Decanoyl chloride were added dropwise to a solution of 2.83 g. 2-(3-chloro-4-cyclohcxylphcnyl)-3-methoxypropanol in 15 ml. pyridine over the course of 5 minutes at 3 - 5°C., with stirring, and the mixture stirred at the same temperature for 2 hours and at ambient temperature for 15 hours. The reaction mixture was poured into a mixture of 50 ml. 10% hydrochloric acid and 50 ml. ethyl acetate, with shaking. The ethyl acetate layer was separated with ice-cooling and the remaining aqueous layer was extracted with 30 ml. ethyl acetate. The extract was combined with the ethyl acetate solution obtained above, washed 4 times with 30 ml. amounts of cold 10% hydrochloric acid, and once each with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was chromatographed on a silica gel column and eluted with a mixture of n-hexane and benzene (1:1 v/v) to give 2.6 g. oily l-decanoyloxy-2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropane.
  • Analysis:
    • calc. for C26H41O3Cl : C 71.45%; H 9.46%; Cl 8.11% found : C 71.30%, H 9.48%; Cl 8.08%
    • I.R.
      Figure imgb0113
      : 1740 cm-1
    • N.M.R. δppmCDCl3 : 0.86 (3H, t, J=5Hz) 1.07 to 2.07 (24H, m) 2.24 (2H, t, J=7Hz) 2.73 to 3.23 (2H, m) 3.30 (3H, s) 3.58 (2H, d, J=6Hz) 4.27 (2H, d, J=6Hz) 7.08 to 7.35 (3H, m)
    Example 30
  • 2.95 g. Palmitoyl chloride were added dropwise to a solution of 2.5 g. 2-(3-chloro-4-cyclohcxylphenyl)-3-methoxypropanol in 13.5 ml. pyridine at 3 - 5°C. over the course of 5 minutes and the mixture stirred at the same temperature for 6 hours.. The reaction mixture was treated in the same manner as described in Example 29 to give 5.2 g. of an oily residue which was chromatographed on a silica gel column and eluted with a mixture of benzene and.n-hexane to give 3.5 g. oily 1-palmitoyloxy-2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropane.
  • Analysis:
    • calc. for C32H53O3Cl : C 73.74%; H 10.23%; Cl 6.80% found : 73.69%; 10.45%; 7.05%
    • I.R.
      Figure imgb0114
      : 1750 cm-1
    • N.M.R. δppmCDCl3 : 0.88 (3H, t, J-5Hz) 1.00 to 2.01 (36H, m) 2.26 (2H, t, J=7Hz) 2.80 to 3.24 (2H, m) 3.34 (3H, s) 3.61 (2H, d, J=6Hz) 4.32 (2H, d, J=7Hz) 7.11 to 7.30 (3H, m)
    Example 31
  • A solution of 2.566 g. propyl 2-(3-chloro-4-cyclo- hexylphcnyl)-3-propoxypropionate in 15 ml. anhydrous diethyl ether was added dropwise over the course of 20 minutes to a cold suspension of 265.7 mg. lithium aluminium hydride in 20 ml. anhydrous diethyl ether, with stirring and ice-cooling, and the mixture stirred at the same temperature for 30 minutes. After decomposing excess lithium aluminium hydride with ethyl acetate, the reaction mixture was shaken with 10% hydrochloric acid and the organic layer was separated. The remaining aqueous layer was extracted with diethyl ether and the extract was combined with the organic layer obtained above, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure to give 2.13 g. oily 2-(3-chloro-4-cyclohexylphenyl)-3-propoxypropanol.
    • I.R.
      Figure imgb0115
      film max : 3400 cm-1
    • N.M.R. δppmCDCl3 : 0.91 (3H, t, J=7Hz) 1.13 to 2.13 (12H, m) 2.67 (lH, t, J=6Hz) 2.73 to 3.30 (2H, m) 3.42 (2H, t, J=6Hz) 3.63 to 4.08 (4H, m) 7.08 to 7.43 (3H, m)
    Example 32
  • To a cold solution of 1.208 g. sodium in 100 ml. n-propanol was added dropwise a solution of 5.849 g. methyl 2-(3-chloro-4-cyclohexylphenyl) acrylate in 20 ml. n-propanol, with stirring and ice-cooling, and the mixture was stirred at ambient temperature for 4 hours. After neutralizing with 3.3 ml. acetic acid, the mixture was evaporated under reduced pressure. The residue was shaken with a mixture of ethyl acetate and water and the ethyl acetate layer was separated. The remaining aqueous layer was extracted with ethyl acetate and the extract was combined with the ethyl acetate layer obtained above, washed with an aqueous sodium bicarbonate solution and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was chromatographed on a silica gel column and eluted with a mixture of n-hexane and benzene (2.5:1 v/v) to give 3.266 g. oily propyl 2-(3-chloro-4-cyclohexylphenyl)-3-propoxy- propionate.
    • I.R.
      Figure imgb0116
      film : 1740 cm-1
    • N.M.R. δppmCDCl3: 0.87 (6H, t, J=7Hz) 1.12 to 2.18 (14H, m) 2.76 to 3.20 (1H, m) 3.40 (2H, t, J=7Hz) 3.54 to 4.31 (5H, m) 7.17 to 7.50 (3H, m)
    Example 33
  • (1) A solution of 1.69 g. diethyl malonate in 2 ml. N,N-dimethylformamide was added dropwise over the course of 5 minutes to a suspension of 506.9 mg. 50% sodium hydride in 10 ml. N,N-dimethylformamide, with stirring and ice-cooling. To the mixture was added dropwise a solution of 3.841 g. 1-tosyloxy-2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropane in 15 ml. N,N-dimethylformamide over the course of 15 minutes, with stirring and ice-cooling, and the mixture stirred at ambient temperature for 10 minutes and then for 3 hours in an oil bath at 100°C. The reaction mixture was shaken with a mixture of water and ethyl acetate and the organic layer was separated. The remaining aqueous layer was extracted with ethyl acetate and the extract was combined with the organic layer obtained above, washed successively with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. Excess diethyl malonate was then also distilled off under reduced pressure. The oily residue obtained was dissolved in a small amount of benzene, chromatographed on a silica gel column and then eluted with benzene to give 2.27 g. oily diethyl 3-(3-chloro-4-cyclohexylphenyl)-4-methoxybutane-1,1-dicarboxylate.
    • I. R.
      Figure imgb0117
      : 1745, 1720 cm-1
    • N.M R. δppmCDCl3 : 1.18 (3H, t, J=7Hz) 1.25 (3H, t, J=7Hz) 0.97 to 2.08 (10H, m) 2.11 to 2.46 (2H, m) 2.61 to 3.59 (5H, m) 3.28 (3H, s) 4.07 (2H, q, J=7Hz) 4.20 (2H, q, J=7Hz) 7.02 to 7.45 (3H, m)
  • (2) A mixtu-e of a solution of 5.094 g. diethyl 3-(3-chloro-4-cyclohexylphenyl)-4-methoxybutane-l,l-dicarboxylate in 50 ml. methanol and a solution of 1.44 g. sodium hydroxide in 10 ml. water was heated under reflux for an hour, with stirring, and then evaporated under reduced pressure. The residue was acidified with 10% hydrochloric acid, with ice-cooling, and then extracted with ethyl acetate. The extract was washed with water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was triturated with a.small amount of n-hexane,'while cooling, and the precipitate was filtered off and washed with n-hexane to give 4.073 g. 3-(3-chloro-4-cyclohexylphcnyl)-4-methoxybutane-1,1-dicarboxylic acid; m.p. 85 - 88°C.
    • I.R.
      Figure imgb0118
      : 1720, 1745 cm-1
    • N.M.R. δppmDMSO-d6: 1.10 to 2.31 (12H, m) 2.63 to 3.13 (3H, m) 3.18 (3H, s) 3.45 (2H, d, J=6Hz) . 7.12 to 7.53 (3H, m)
  • (3) A solution of 3.685 g. 3-(3-chloro-4-cyclohexylphenyl)-4-methoxybutane-1,1-dicarboxylic acid in 10 ml. xylene was heated under reflux for 30 minutes and then evaporated under reduced pressure. The oily residue was dissolved in 10 ml. methanol and mixed with a solution of 380 mg. sodium hydroxide in 10 ml. methanol. The mixture was stirred for some time and then evaporated to dryness under reduced pressure. The residue was triturated with n-hexane with cooling, and the precipitate was filtered off, recrystallized from a mixture of diethyl ether and n-hexane and then washed with n-hexane to give 2.779 g. sodium 4-(3-chloro-4-cyclohexylphenyl)-5-methoxyvalerate; m.p. 273 - 276°C. (dec.).
    • I.R.
      Figure imgb0119
      : 1590 cm-1
    • N.M.R. δppmD2O : 0.89 to 2.36 (12H, m) 2.53 to 3.59 (6H, m) 3.13 (3H, s) 6.86 to 7.30 (3H, m)
    Example 34
  • To a cold solution of 3.45 g. sodium in 100 ml. anhydrous n-propanol was added dropwise over the course of 20 minutes a solution of 12.75 g. methyl 2-(4-cyclohcxylphcnyl)acrylate in 30 ml. n-propanol with stirring and ice-cooling, and the mixture was stirred at ambient temperature for 7 hours. The reaction mixture was treated in a similar manner to that of Example 32 to give 11.56 g. oily n-propyl 2-(4-cyclohexylphenyl)-3-n-propoxypropionate.
    • I.R.
      Figure imgb0120
      : 1730 cm-1
    • N.M.R.
      Figure imgb0121
      : 0.83 (6H, t, J=8Hz) 1.04 to 2.10 (14H, m) 2.27 to 2.68 (1H, m) 3.38 (2H, t, J=8Hz) 3.51 to 4.23 (5H, m) 7.04 to 7.35 (411, m)
    Example 35
  • A solution of 4.761 g. sodium in 100 ml. anhydrous methanol was added dropwise over the course of 20 minutes to a solution of 23.357 g. methyl 2-(3-chloro-4-cyclohcxylphcnyl)-3-acetoxypropionate in 25 ml. anhydrous methanol with stirring and ice-cooling. The mixture was treated in a similar manner to that of Example 17-(1) to give 20.99 g. oily residue. The residue was dissolved in a small amount of n-hexane, the solution was chromatographed on a silica gel column and then elutcd successively with n-hexane, n-hexanc and benzene (1:1 v/v) and n-hexane and benzene (1:2.v/v). The fraction of n-hexane and benzene (1:2 v/v) was evaporated to dryness under reduced pressure to give 12.98 g. oily methyl 2-(3-chloro-4-cyclohcxylphenyl)-3-methoxypropionate.
    • I.R.
      Figure imgb0122
      : 1735 cm-1
    • N.M.R.
      Figure imgb0123
      : 1.04 to 2.10 (10H, m) 2.96 (1H, broad s) 3.34 (3H, s) 3.48 to 4.04 (3H, m) 3.68 (3H, s) 7.06 to 7.46 (3H, m)
    Example 36
  • A solution of 4.954 g. decanoyl chloride in 5 ml. methylene chloride was added dropwise over the course of 1 hour to a solution of 3.222 g. 2-(3-chloro-4-cyclohexylphenyl)propane-1,3-diol and 2.666 g. triethylamine in 25 ml. methylene chloride, with stirring and ice-cooling, stirred at the same temperature for 4 hours. The solvent was distilled off under reduced pressure, and ethyl acetate and water were added to the resultant residue. After shaking, the organic layer was separated and washed successively with an aqueous solution of sodium bicarbonate, water, 10% hydrochloric acid, and water, dried over anhydrous magnesium sulphate and evaporated. The oily residue was dissolved in a small amount of n-hexane, the solution was chromatographed on a silica gel column and eluted successively with n-hexane, n-hexane and benzene (2:1 v/v), n-hexane and benzene (1:1 v/v) to give 4.387 g. oily 1,3-di-n-decanoyloxy-2-(3-chloro-4-cyclohexylphcnyl)propane.
  • Analysis:
    • Calc. for C35H57CℓO4: C 72.82%; H 9.95%; Cℓ 6.14%
    • found : C 72.61%; H 9.90%, Cℓ 6.70%
    • I.R.
      Figure imgb0124
      : film 1740 cm-1
    • N.M.R.
      Figure imgb0125
      : 0.89 (6H, t, J=6Hz) 1.07 to 2.10 (38H, m) 2.30 (4H, t, J=7Hz) 2.79-3.53 (2H, m) 4.35 (4H, d, J=7Hz) 7.13-7.38 (3H, m)
    Example 37
  • 1.632 g. 50% sodium hydride was added to a solution of 10.74 g. 2-(3-chloro-4-cyclohexylphenyl)-propane-1,3-diol in 50 ml. dimcthylformamide and stirred for 10 minutes under ice-cooling. 10 ml. Petroleum ether was added to the mixture and stirred at ambient temperature for 1.5 hours. 5.436 g. n-Pentyl bromide was added dropwise to the mixture over the course of 30 minutes, and stirred at ambient temperature for 3 hours. Water and ethyl acetate were added to the reaction mixture. After shaking, the organic layer was separated, washed with water, dried over anhydrous magnesium sulphate and then evaporated to dryness under reduced pressure. The oily residue was dissolved in n-hexane and the solution was left to stand at ambient temperature, filtered and then washed with n-hexane. The filtrate and the washings were combined and evaporated under reduced pressure. The residue was dissolved in a small amount of benzene chromatographed on a silica gel column and eluted successively with benzene and chloroform to give 5.61 g. 3-n-pentyloxy-2-(3-chloro-4-cyclohexylphenyl)propanol.
  • Analysis:
    • Calc. for C20H31CℓO2 : C70.88%; H 9.22 %; Cℓ 10.46%
    • found : C 70.93%; H 9.28%; Cℓ 10.64%
    • I.R.
      Figure imgb0126
      film 3400 cm-1
    • N.M.R.
      Figure imgb0127
      : 0.89 (3H, t, J=7Hz) 1.03-2.08 (16H, m) 2.71 (1H, t, J=6Hz) 2.80-3.24 (2H, m) 3.43 (2H, t, J=6Hz) 3.58-4.06 (4H, m) 6.98-7.30 (3H, m)
    Example 38
  • (1) A solution of 2.133 g. benzoylchloride in 10 ml. methylene chloride was added dropwise over the course of 20 minutes to a mixture of 4.078 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-3-aminopropionate, 1.673 g. triethylamine and 30 ml. methylene chloride, with stirring and ice-cooling, stirred at the same temperature for 30 minutes and further at ambient temperature for 1 hour, and then left to stand over- night at the same temperature. The reaction mixture was treated in a similar manner to that of Example 14-(2) to give 6.03 g. oily methyl 2-(3-chloro-4-cyclohexylphenyl)-3-benzamidopropionate.
    • I.R.
      Figure imgb0128
      film 3300, 1725 cm-1
  • (2) A solution of 5.993 g.methyl 2-(3-chloro-4-cyclohexylphenyl)-3-benzamidopropionate and 1.2 g. sodium hydroxide in 30 ml. methanol and 10 ml. water was heated under reflux for 30 minutes, while stirring. Methanol was distilled off under reduced pressure. The residual mixture was adjusted to pH 1 with 10% hydrochloric acid and extracted with ethyl acetate. The extract was washed with water, dried over anhydrous magnesium sulfate and then evaporated under reduced pressure. Precipitated crystals were recrystallized from methanol to give 2.59 g. 2-(3-chloro-4-cyclohcxyl- phenyl)-3-benzamidopropionic acid; mp. 197.5-199°C.
  • Analysis:
    • Calc. for C22H24CℓNO3 : C 68.48%; H 6.27%; N 3.63%; Ct 9.19%
    • found : C 68.32%; H 6.12%; N 3.64%; Cℓ 9.36%
    • I.R. νNujol max : 3360, 1700, 1640 cm-1
    • N.M.R.
      Figure imgb0129
      : 0.98 to 1.98 (10H, m) 2.88 (1H, broad, s) 3.26 to 3.84 (2H, m) 3.94 (1H, d,d, J=7Hz, 15Hz) 7.10 to 7.54 (6H, m) 7.60 to 7.86 (211, m) 8.34 to 8.66 (1H, m)
    Example 39
  • (1) A solution of 1.14 g. methyl isocyanate in 10 ml. methylene chloride was added dropwise over the course of 15 minutes to a solution of 5.91 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-3-aminopropionate in 30 ml. methylene chloride, with stirring and ice-cooling, and stirred at the same temperature for 25 minutes. The reaction mixture was evaporated to dryness under reduced pressure to give 6.86 g. oily methyl 2-(3-chloro-4-cycloliexylphenyl)-3-(3-methylureido)propionate.
    • I.R.
      Figure imgb0130
      : 3350 1720 1630 cm-1
    • N.M.R. δDMSO ppm : 1.06 to 2.08 (10H, m) 2.53 (3H, d, J=4Hz) 2.88 (1H, broad s) 3.24 to 3.68 (2H, m) 3.61 (3H, s) 3.84 (1H, t, J=9Hz) 5.78 (1H, q, J=4Hz) 6.02 (1H, t, J=6Hz) 7.12 to 7.40 (3H, m)
  • (2) A solution of 6.698 g. methyl 2-(3-chloro-4-cyclohexylphenyl)-3-(3-methylureido)propionate and 1.14 g. sodium hydroxide in 50 ml. methanol was heated under reflux for 1 hour, while stirring. Methanol was distilled off under reduced pressure, and the residue was dissolved in water, washed with ethyl acetate and then adjusted to pH 1 with 10% hydrochloric acid. The precipitated crystals were collected by filtration with suction, washed with water, dried, and recrystallized from methanol to give 3.220 g. 2-(3-chloro-4-cyclohexylphenyl)-3-(3-methylureido)propionic acid; mp. 188.5 - 190°C (decomp.).
  • Analysis:
    • Calc. for C17H23CℓN2O3 : C 60.26%; H 6.84%; N 8.27%; Cℓ 10.46%
    • found : C 60.37%; H 6.96%; N 8.18%; Cℓ 10.57%
    • I.R.
      Figure imgb0131
      : 3400, 1735, 1580 cm-1
    • N.M.R.
      Figure imgb0132
      : 0.96 to 2.00 (10H, m) 2.51 (3H, d, J=5Hz) 2.90 (1H, broad s) 3.18 to 3.58 (2H, m) 3.70 (1H, d,d, J=7, 12Hz) 5.84 (1H, q, J=5Hz) 6.00 (1H, t, J=5Hz) 7.28 to 7.46 (3H, m)
    Example 40
  • A mixture of 3.855 g. 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionic acid, 20 ml. n-butanol and 1 ml. conc. sulfuric acid was stirred at 100°C for 30 minutes. The reaction mixture was evaporated under reduced pressure and the residue was shaken with a mixture of ethyl acetate and cold water. The organic layer was separated,washed successively with water, a saturated aqueous solution of sodium bicarbonate and water, dried over anhydrous magnesium sulphate and then evaporated under reduced pressure. The oily residue was fractionated by vacuum distillation to give 2.833 g. n-butyl 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionate; b.p. 185°-187°C/5 mm.Hg.
    • I.R.
      Figure imgb0133
      1745 cm-1 max
    • N.M.R.
      Figure imgb0134
      : 0.87 (3H, t, J=6Hz) 1.10 to 2.07 (lH, m) 2.73 to 3.10 (lH, m) 3.36 (3H, s) 3.50 to Ca. 4.00 (3H, m) 4.13 (2H, t, J=6Hz) 7.15 to 7.41 (3H, m)

Claims (8)

1. A compound of the formula:-
Figure imgb0135
wherein R1 is a lower cycloalkyl radical,
R2 is a carboxy, eaterified carboxy, hydroxymethyl, lower alkoxymethyl or acyloxymethyl radical,
R3 is a lower alkanoyl radical or a lower alkyl radical substituted with a hydroxy, amino, lower alkylamino, di(lower)-alkylamino, acylamino, lower alkoxy, acyl or acyloxy radical, in which the lower alkyl moieties of the di(lower)alkyl amino radical may be joined together to form a heterocyclic ring containing the nitrogen atom, and the carbonyl function of the acyl radical, which is a substituent on the lower alkyl radical, may be protected,
X ia a hydrogen or halogen atom, and
Y is a valency bond or a lower alkylene radical;

and the pharmaceutically acceptable salts thereof.
2. A process for preparing a compound of the formula:-
Figure imgb0136
wherein R1 is a lower cycloalkyl radical,
R 2 is a carboxy, esterified carboxy, hydroxymethyl, lower alkoxymethyl or acyloxymethyl radical,
R 3 is a lower alkanoyl radical or a lower alkyl radical substituted with a hydroxy, amino, lower alkylamino, di(lower)alkylamino, acylamino, lower alkoxy, acyl or acyloxy radical, in which the lower alkyl moieties of the di(lower)alkylamino radical may be joined together to form a heterocyclic ring containing the nitrogen atom, and the carbonyl function of the acyl radical, which is a substituent on the lower alkyl radical may be protected,
X is a hydrogen or halogen atom, and
Y is a valency bond or a lower alkylene radical;
or a pharmaceutically acceptable salt thereof, which comprises
(1) reacting a compound of the formula:-
Figure imgb0137
wherein R1, R 2, X and Y have the same meanings as above, with a lower alkanoic acid of the fomula:-
Figure imgb0138
wherein
Figure imgb0139
is a lower alkanoyl radical, or a reactive derivative thereof to give a compound of the formula:-
Figure imgb0140
wherein Rl, R2,
Figure imgb0141
, X and Y have the same meaning as above;
(2) reacting a compound of the formula:-
Figure imgb0142
wherein R1, R2, X and Y have the same meanings as above, with paraformaldehyde to give a compound of the formula:-
Figure imgb0143
wherein R1, R2,
Figure imgb0144
, X and Y have the same meanings as above;
(3) reducing a compound of the formula:-
Figure imgb0145
wherein R 1, R 2, X and Y have the same meanings as above and
Figure imgb0146
is a lower alkanoyl radical, to give a compound of the formula:-
Figure imgb0147
wherein R1, R2, X and Y have the same meanings as above and
Figure imgb0148
is a hydroxy(lower)alkyl radical, or a compound of the formula:-
Figure imgb0149
wherein R1, R3, X and Y have the same meanings as above;
(4) reacting a compound of the formula:-
Figure imgb0150
wherein R1, R 2, X and Y have the same meanings as above and
Figure imgb0151
is a hydroxy(lower)alkyl or acyloxy-(lower)alkyl radical, with an alkylating agent to give a compound of the formula:-
Figure imgb0152
wherein R1, R2, X and Y have the same meanings as above and
Figure imgb0153
is a lower alkoxy(lower)alkyl radical;
(5) reacting a compound of the formula:-
Figure imgb0154
wherein R1, R 2, X and Y have the same meanings as above, with an alkylating agent to give a compound of the formula:-
Figure imgb0155
wherein R1, R2, X and Y have the same meanings as above and
Figure imgb0156
is a lower alkoxymethyl radical:
(6) reacting a compound of the formula:-
Figure imgb0157
wherein R1, R2, X and Y have the same meanings as above and
Figure imgb0158
is a hydroxy(lower)alkyl radical, with an acylating agent to give a compound of the fossula:-
Figure imgb0159
wherein R1, R2, X and Y have the same measings as above and
Figure imgb0160
is an acyloxy(lower)alkyl radical;
(7) reacting a compound of the formula:-
Figure imgb0161
wherein R1, R2, X and Y have the same meanings as above and
Figure imgb0162
is an acyloxy(lower)alkyl radical, with ammonia or an amine compound selected from alkylamines, di(lower)alkylamines and saturated heterocyclic imine compounds containing an imino group, or a compound of the formula:-
Figure imgb0163
wherein R1, R 2, X and Y have the same meanings as above, with ammonia or a lower alkylamine, di(lower)-alkylamine or saturated heterocyclic compound containing an imion group, in the presence of a reducing agent to give a compound of the formula:-
Figure imgb0164
wherein R l, R 2, X and Y have the same meanings as above and
Figure imgb0165
is a lower alkyl radical substituted by an amino, lower alkylamino or di(lower)alkylamino group, in which the lower alkyl moieties of the di(lower)alkylamino group can be joined together to form a heterocyclic ring containing the nitrogen atom;
(8) reacting a compound of the formula:-
Figure imgb0166
wherein R1, R2, X and Y have the same meanings as above and R3' g is an amino(lower)alkyl radical, with an acylating agent to give a compound of the formula:-
Figure imgb0167
wherein R1, R2, X and Y have the same meanings as above and R3 is an acylamino(lower)alkyl radical;
(9) reacting a compound of the formula:-
Figure imgb0168
wherein R1, R2, X and Y have the same meanings as above and
Figure imgb0169
is a hydroxy(lower)alkyl or acyloxy-(lower)alkyl radical, or a compound of the formula:-
Figure imgb0170
wherein R1, R2, X and Y have the same meanings as above, with an aryl-subatituted or unsubstituted nitro(lower)alkane in the presence of a strong base, followed by treating the resultant compound with a mineral acid or an oxidising agent to give a compound of the formula:-
Figure imgb0171
wherein R1, R2, X and Y have the same meanings as above and
Figure imgb0172
is an acyl(lower)alkyl radical;
(10) hydrolysing a compound of the formula:-
Figure imgb0173
wherein R1, R3, X and Y have the same meanings as above and
Figure imgb0174
is an esterified carboxy group, to give a compound of the formala:-
Figure imgb0175
wherein R1, R 3, X and Y have the same meanings as above and Rf ia a carboxy radical;
(11) reacting a compound of the formula:-
Figure imgb0176
wherein R1, R3, X and Y have the same meanings as above and
Figure imgb0177
is an acyloxymethyl radical, with a diester of malonic acid in the presence of a baae, and then hydrolyzing the resultant compound of the formula:-
Figure imgb0178
wherein R 1, R 3, X and Y have the same meanins as above and COOR is an esterified carboxy group, and finally decarboxylating the resultant dicarboxylic acid to give a compound of the formula:-
Figure imgb0179
wherein Rl,
Figure imgb0180
, R3, X and Y have the same meanings as above;
(12) reducing a compound of the formula:-
Figure imgb0181
wherein R1, R3, X and Y have the same meanings as above and
Figure imgb0182
is a carboxy or esterified carboxy group to give a compound of the formula:-
Figure imgb0183
wherein R1, R3, X and Y have the same meanings as above and
Figure imgb0184
is a hydroxymethyl radical;
(13) acylating a compound of the formula:-
Figure imgb0185
wherein Rl, R3, X and Y have the same meanings as above, to give a compound of the formula:-
Figure imgb0186
wherein R1, R 3, X and Y have the same meanings as above and
Figure imgb0187
is an acyloxymethyl radical;
(14) oxidising a compound of the formula:-
Figure imgb0188
wherein R1, R3, X and Y have the same meanings as above, to give a compound of the fomula:-
Figure imgb0189
wherein Rl, R3, X and Y have the same meanings as above, or
(15) esterifying a compound of the formula:-
Figure imgb0190
wherein R1, R 3, X and Y have the same meanings as above, to give a compound of the formla:-
Figure imgb0191
wherein R l, R 3, X and Y have the same meanings as above, and
Figure imgb0192
is as esterified carboxy radical.
3. A pharmaceutical composition comprising a compound of the claim 1 as active inqredient, in association with a pharmaceutically-acceptable, substantially non-toxic carrier or excipient.
4. A method for treating an inflammation, which comprises administering a compound of the claim 1 to a mammal.
5. Sodium 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionate.
6. 2-(3-Chloro-4-cyclohexylphenyl)-3-methoxypropionic acid.
7. Methyl 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionate.
8. n-Butyl 2-(3-chloro-4-cyclohexylphenyl)-3-methoxypropionate.
EP78300168A 1977-07-19 1978-07-19 Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions Withdrawn EP0000644A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3022977 1977-07-19
GB3022977 1977-07-19

Publications (2)

Publication Number Publication Date
EP0000644A2 true EP0000644A2 (en) 1979-02-07
EP0000644A3 EP0000644A3 (en) 1979-09-19

Family

ID=10304339

Family Applications (1)

Application Number Title Priority Date Filing Date
EP78300168A Withdrawn EP0000644A3 (en) 1977-07-19 1978-07-19 Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions

Country Status (3)

Country Link
EP (1) EP0000644A3 (en)
JP (1) JPS5422348A (en)
IT (1) IT1109502B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0281876U (en) * 1988-12-14 1990-06-25
JPH02131481U (en) * 1989-04-10 1990-11-01

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5198M (en) * 1964-06-15 1967-06-26 Merck & Co Inc
FR1568773A (en) * 1967-11-21 1969-05-30
US3876800A (en) * 1969-05-12 1975-04-08 Clin Midy Pharmaceutical compositions and methods for treating inflammation and pain
US3919304A (en) * 1968-10-25 1975-11-11 Ciba Geigy Corp {62 -Hydroxy-{62 -(cycloalkenylphenyl)alkanoic acids, esters and salts

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5198M (en) * 1964-06-15 1967-06-26 Merck & Co Inc
NL7011847A (en) * 1964-06-15 1970-12-28 Merck & Co Inc
FR1568773A (en) * 1967-11-21 1969-05-30
US3919304A (en) * 1968-10-25 1975-11-11 Ciba Geigy Corp {62 -Hydroxy-{62 -(cycloalkenylphenyl)alkanoic acids, esters and salts
US3876800A (en) * 1969-05-12 1975-04-08 Clin Midy Pharmaceutical compositions and methods for treating inflammation and pain

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound

Also Published As

Publication number Publication date
IT7825878A0 (en) 1978-07-19
JPS5422348A (en) 1979-02-20
IT1109502B (en) 1985-12-16
JPS6141333B2 (en) 1986-09-13
EP0000644A3 (en) 1979-09-19

Similar Documents

Publication Publication Date Title
AU613026B2 (en) 2',3' dideoxyribofuranoxide derivatives
US5604261A (en) Arylalkyl (thio)amides
AU768726B2 (en) Indole derivatives and their use for the treatment of osteoporosis amongst other applications
CA1215363A (en) Substituted lactams as angiotensinase inhibitors
JPS6059226B2 (en) Proline derivatives and related compounds
US3075992A (en) Esters of indoles
EP0187322A1 (en) Carbostyril compounds, compositions containing same and processes for preparing same
NO763724L (en)
IE45015B1 (en) New oxime derivatives of 7-aminothiazolylacetamido-cephalosporanic acid, processes for preparing them and pharmaceutical compositions incorporating them
US4857644A (en) Aryl sulfonopiperazines as anti-inflammatory agents
EP2906560B1 (en) Azaindolines having activity as inhibitors of iap
US4442295A (en) 3-Cyano indoles as intermediates for cardioselective compounds
HU202508B (en) Process for producing new 1,4-disubstituted piperazine derivatives and pharmaceutical compositions containing them as active components
EP0000644A2 (en) Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions
EP0082712B1 (en) 2-phenylimidazo(2,1-b)benzothiazole compounds, salts thereof, process for producing them, and pharmaceutical compositions containing them
EP2483246B1 (en) Process for preparing biphenyl imidazole compounds
US4757078A (en) Cyclic aryl hydroxamic acids, derivatives thereof and method of use as anti-allergy agents
CS268189B2 (en) Method of quinazolinediones and pyridopyrimidinodiones production
HU192836B (en) Process for producing substituted azabicyclo-alkane derivatives and pharmaceutical compositions containing them
US2983755A (en) Process for the preparation of 1-(p-nitrophenyl)-2-acylamido-propane-1, 3-diols
US4235921A (en) Treating muscular spasms and convulsions with 3-azabicyclo[3.1.0]hexanes
CZ20011324A3 (en) Process for preparing beta-alanine derivatives
PL111408B1 (en) Process for the preparation of novel derivatives of pyrolo-1-carboxylic acid
US6069257A (en) Process for the production of tetrazolylbenzopyrans
JPH0523259B2 (en)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): BE CH DE FR GB LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): BE CH DE FR GB LU NL SE

17P Request for examination filed
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19811019

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SHIOKAWA, YOUICHI

Inventor name: KAMIYA, TAKASHI